UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):  July 19 , 2018

 

AEON GLOBAL HEALTH CORP.
(Exact name of registrant as specified in its charter)

 

COMMISSION FILE NUMBER :   0-20190

 

DELAWARE

14-1673067

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

 

2225 C ente nn ial Drive

Gainesville, GA 30504

(Address and zip code of principal executive offices)

 

1- ( 88 8) 661 -0 225
(Registrant’s telephone number, including area code

 

___________________________________________

(Former Name, if Changed Since Last Report)

 

CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS: 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

Item  1 .0 1

Entry into a Material Definitive Agreement.

 

Settlement and Restructuring Agreement

 

On July 19, 2018, Aeon Global Health Corp. (the “Company”) entered into a Settlement and Restructuring Agreement (the “Agreement”) with Peachstate Health Management, LLC (“Peachstate”), its wholly-owned subsidiary, and the former members of Peachstate included in the Agreement (the “Former Members”), including its chief executive officer, Hanif A. Roshan. Pursuant to the Agreement, the parties agreed to, among other things, resolve certain disagreements among themselves relating to the interpretation of certain provisions of the Amended and Restated Agreement and Plan of Merger dated as of January 26, 2016, and as subsequently amended (the “Merger Agreement”) pursuant to which Peachstate became a wholly-owned subsidiary of the Company (the “Merger”).

 

The Merger Agreement included, among other things, certain earnout consideration (the “Earnout”) and the assumption of certain liabilities. The Earnout required the achievement of certain EBITDA levels that were automatically adjusted upon the change of reimbursement rates adopted by the Centers for Medicare and Medicaid Services. Upon achievement of the EBITDA level for the three calendar years ending December 31, 2018 (“2018 Earnout”), the Former Members would receive additional shares of the Company’s Common Stock so that the total number of shares of the Company’s Common Stock issued to the Former Members pursuant to the Merger Agreement would equal 85% of the issued and outstanding shares of the Company’s Common Stock on a post-issuance and fully-diluted (as defined in the Merger Agreement) basis. In addition, the Merger Agreement provided that upon achievement of the EBITDA level for the four calendar years ending December 31, 2019 (“2019 Earnout”), the Former Members would receive additional shares of the Company’s Common Stock so that the total number of shares of the Company’s Common Stock issued to them pursuant to the Merger Agreement would equal 90% of the issued and outstanding shares of the Company’s Common Stock on a post-issuance and fully-diluted (as defined in the Merger Agreement) basis. The Former Members were also granted certain registration rights pursuant to the Merger Agreement (the “Registration Rights”), which remain outstanding. Achievement of the maximum amount of Earnout would have resulted in the issuance of over 70,000,000 shares of the Company’s Common Stock.

 

Subsequently, in connection with the Merger, the parties expressed differences of opinion on the interpretation of certain provisions of the Merger Agreement, the calculation of the number of shares of Common Stock issued pursuant to the initial tranches of the Earnout under the Merger Agreement, and the assumption of income tax liabilities for undistributed income earned by Peachstate prior to the Merger. The Company has also incurred negative cash flow for the calendar years 2016 and 2017, necessitating the loan of approximately $760,000 by the Company’s chief executive officer in addition to an amount of $591,613, including accrued interest, previously loaned by an entity owned by certain of the former members of Peachstate (collectively the “Loans”), which Loans have been extended on multiple occasions. The Loans are due and payable on March 20, 2019 and are convertible into Common Stock at $1.20 per share (currently 1,126,235 shares). In addition, the Chief Executive Officer and certain of the former members of Peachstate reduced their cash compensation as employees to zero and have been accepting restricted stock units of the Company as sole compensation.

 

The Company, Peachstate and the Former Members reached an agreement to resolve these matters and entered into the Agreement in order to: (i) provide a source of working capital to the Company to sustain operations and reduce the additional dilution which could have been caused by the conversion of the Loans; (ii) remove the uncertainty as to the number of shares which may be issued pursuant to the 2018 and 2019 Earnouts by replacing percentages with fixed share amounts; (iii) agree that all share calculations for the Earnouts are to be based on actual shares outstanding rather than on a “fully-diluted” basis to provide additional certainty and reduce the potential issuances on account of the Merger from approximately 70,000,000 shares of Common Stock to approximately 11,000,000 shares of Common Stock; (iv) provide clarity as to the relationship between the 2018 Earnout and 2019 Earnout; (v) reduce the maximum percentage ownership of the former members of Peachstate; (vi) avoid the expense of a demand registration statement; and (vii) otherwise resolve all outstanding disagreements among the parties arising out of the Merger Agreement.

 

As a condition to the effectiveness of the Agreement, the parties agreed to restructure the Loans to exchange the existing notes held by such persons for a new senior credit instrument pursuant to which the lenders would provide up to $2.0 million of credit to Company (the “Note Restructuring Transaction”). A summary of the Note Restructuring Transaction is set forth below.

 

 

 

 

The parties also resolved all interpretative issues relating to the Merger Agreement and clarified the amount and terms of the Earnouts as described below.

 

With respect to the 2018 Earnout, the parties agreed that the 2018 Earnout, as adjusted according to the Merger Agreement, shall be $21,483,749 of EBITDA for the three calendar years ending December 31, 2018. If the 2018 Earnout target is achieved, then on October 1, 2019, subject to the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2018, the Company shall issue the Former Members a fixed amount of 3,000,000 shares of the Company’s Common Stock; provided, however, that if Peachstate does not achieve the 2018 Earnout target, but achieves EBITDA for the three calendar years ending December 31, 2018 of at least 75% of the 2018 Earnout target, then on October 1, 2019, subject to the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2018, the Company shall issue the Former Members a fixed amount of 2,250,000 shares of the Company’s Common Stock.

 

With respect to the 2019 Earnout, the parties agreed that the 2019 Earnout, as adjusted according to the Merger Agreement, shall be $32,600,530 of EBITDA for the four calendar years ending December 31, 2019. If the 2019 Earnout target is achieved, then within three business days following the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2019, the Company shall issue the Former Members a fixed amount of 4,000,000 shares of the Company’s Common Stock. If Peachstate fails to achieve the 2019 Earnout target, but achieves EBITDA for the four calendar years ending December 31, 2019 of at least 75% of the 2019 Earnout target, then within three business days following the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2019, the Company shall issue the Former Members a fixed amount of 3,000,000 shares of the Company’s Common Stock.

 

The parties also agreed that if the 2019 Earnout target is achieved the Former Members would be entitled to an “earnout credit” equal to the amount by which such target is exceeded. If Peachstate did not achieve the 2018 Earnout target (or the adjusted 2018 Earnout target), the earnout credit would be applied to Peachstate’s EBITDA for the 2018 Earnout and then the determination of whether the 2018 Earnout was achieved (at either the full or the 75% level) will be recomputed. If the addition of the earnout credit results in Peachstate’s achieving the 2018 Earnout (at either level) then a number of additional shares of Common Stock shall be issued to the Former Members in accordance with the terms of the Settlement Agreement.

 

The Company also agreed that in consideration of the restructuring of the consideration due to the Former Members under the Merger Agreement, it shall issue an aggregate of 2,500,000 shares of the Company’s Common Stock to the Former Members. Such additional shares shall be issued to the Former Members pro rata based on their respective percentage ownership of Peachstate prior to the Merger and shall be deemed earned and issued on February 28, 2019.

 

As additional consideration to the Company under the Agreement, the Former Members agreed: (i) to relinquish all demand registration rights; (ii) that the arrangements set forth in the Agreement fully resolved any and all claims arising out of the Merger Agreement and the transactions contemplated thereby; and (iii) to a general release of claims as against the Company.

 

Note Restructuring Transaction

 

As a condition to the effectiveness of the Agreement, the parties further agreed to restructure the loans previously made to the Company by Mr. Roshan and Optimum Ventures, LLC, an entity affiliated by ownership with the former members of Peachstate Health Management, LLC (together, the “Lenders”) and to exchange the existing notes held by such persons for a new senior credit instrument pursuant to which they will provide up to $2.0 million of credit to Company (the “Note Restructuring Transaction”). In the Note Restructuring Transaction, the Company entered into a note exchange agreement dated July 19, 2018 (the “Exchange Agreement”), with the Lenders, who collectively held senior secured convertible notes in the aggregate principal amount of $1,351,482 (the “Original Notes”).

 

Pursuant to the Exchange Agreement, the Company agreed to issue the Lenders new senior secured grid notes in the aggregate principal amount of $2.0 million (the “Grid Notes”) in consideration of the cancellation of their Original Notes. The Grid Notes are structured to provide the Company with a credit facility pursuant to which it can borrow, pay, and re-borrow any portion of the maximum principal amount of credit available under these instruments. The Grid Notes are senior, secured obligations and are not convertible into any equity securities of the Company. The Grid Notes bear interest at the rate of 7.5% per annum with interest payable upon maturity or sooner in accordance with the prepayment mechanism of the Grid Notes. The maturity date of the Grid Notes is June 30, 2020.

 

 

 

 

Subject to certain exceptions, the Grid Notes are on parity with an outstanding principal amount of $1,698,169 of other senior secured convertible notes (the “Senior Convertible Notes”) and, subject to certain exceptions, are senior to other existing and future indebtedness of the Company and, together with the Senior Convertible Notes, will be secured by a first priority lien on all of the Company’s assets to the extent and as provided in a Security Agreement entered into between the Company, the Lenders and the holders of the Senior Convertible Notes (the “Convertible Note Holders”). The Grid Notes contain customary covenants against incurring additional indebtedness and granting additional liens and contains customary events of default, which terms are substantially the same as the corresponding provisions of the Original Notes. Upon the occurrence of an event of default under the Grid Notes, the Lenders may require the Company to repay all or a portion of the note in cash, at a price equal to 110% of the principal, plus accrued and unpaid interest.

 

The Grid Notes are being issued in consideration of the exchange of (i) an aggregate principal amount of $759,869 of Original Notes held by Mr. Roshan and (ii) an aggregate principal amount of $591,613 of Original Notes held by Optimum Ventures, LLC. Upon the closing, a Grid Note was issued to each of the Lenders in a maximum principal amount based on the relative percentages of the Original Notes that were held by them. The maximum principal amount under the Grid Note issued to Mr. Roshan is $1,100,000 and the maximum principal amount under the Grid Note issued to Optimum is $900,000. Each Grid Note issued also reflects an outstanding principal amount equal to the sum of the aggregate principal amount of the Original Notes held by each Lender, plus the accrued but unpaid interest thereon. The closing of the Note Restructuring Transaction occurred on July 19, 2018.

 

In connection with the Note Restructuring Transaction, the Company entered into a consent and amendment agreement with the Convertible Note Holders (the “Consent Agreement”) to obtain their consent to the issuance of the Grid Notes on the terms described above. In consideration thereof, the Company and Convertible Note Holders also agreed to extend the maturity date of the Senior Convertible Notes for a period of one year to March 20, 2020 and to modify the redemption mechanism of such instruments by increasing the duration of the redemption notice period defined in the Senior Convertible Notes. In addition, the Company, the Lenders and Convertible Note Holders entered into an amendment to the Amended and Restated Security Agreement entered into as of March 20, 2017, as previously amended (the “Security Agreement”), to provide that the Grid Notes shall be secured by the collateral defined in such earlier Security Agreement.

 

The foregoing summary does not purport to be a complete description of the terms of the Settlement and Restructuring Agreement, Exchange Agreement, Consent Agreement, Security Agreement or the Grid Notes and is qualified in its entirety by reference to the full text of such documents, copies of which are filed as exhibits to this Current Report on Form 8-K and which are incorporated herein by reference.

 

Item  2 .0 3

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

The information included in Item 1.01 of this Form 8-K regarding the Note Restructuring Transaction is hereby incorporated by reference into this Item 2.03.

 

Item 3.02

Unregistered Sales of Equity Securities.

 

The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02. The offers and sales of the securities pursuant to the Settlement and Restructuring Agreement and Exchange Agreement have been determined to be exempt from registration under the Securities Act of 1933, in reliance on Section 4(a)(2) thereof, as transactions by an issuer not involving a public offering, in which the investors are accredited and have acquired the securities for investment purposes and not with a view to or for sale in connection with any distribution thereof. These securities have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This disclosure does not constitute an offer to sell or the solicitation of an offer to buy any of the Company’s securities, nor will there be any sales of these securities by the Company in any state or jurisdiction in which the offer, solicitation or sale would be unlawful.

 

 

 

 

Item 9.01

Financial Statements and Exhibits .

   

(d)

Exhibits

   

The following exhibits are attached to this Form 8-K:

   

Exhibit No.

Exhibit Title or Description

4.1

Form of Grid Note

10.1

Form of Settlement and Restructuring Agreement

10.2

Form of Note Exchange Agreement

10.3

Form of Consent and Amendment Agreement

10.4

Form of Amendment to Amended and Restated Security Agreement

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

 

AEON GLOBAL HEALTH CORP.

     

 

 

 

 

 

By: /s/ Michael J. Poelking  

 

 

Name: Michael J. Poelking

 

 

Title:   Chief Financial Officer 

 Date:   July 24, 2018

 

 

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit
Number

Description                                                                                                      

4.1

Form of Grid Note

10.1

Form of Settlement and Restructuring Agreement

10.2

Form of Note Exchange Agreement

10.3

Form of Consent and Amendment Agreement

10.4

Form of Amendment to Amended and Restated Security Agreement

 

 

  Exhibit 4.1

 

THIS NOTE HA S NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST.

 

AEON GLOBAL HEALTH CORP.

SENIOR SECURED GRID N OTE

 

Maximum Principal Amount:     $[1,100,000.00.00]/[900,000.00]   Issuance Date : July 19, 2018
  Maturity Date : June 30, 2020

 

 

FOR VALUE RECEIVED, AEON GLOBAL HEALTH CORP., a Delaware corporation (the “ Borrower ”), with its principal offices located at 2225 Centennial Drive, Gainesville, GA 30504, hereby issues this Senior Secured Grid Note (this “ Note ”) and unconditionally promises to pay to the order of [Hanif A. Roshan]/[Optimum Ventures, LLC] (the “ Holder ” or “ Lender ”) at such address as the Lender designates in writing to the Borrower, the principal sum of funds as has been advanced from time to time (“ Principal Amount ”), less amounts repaid, as recorded by the Lender in the column headed “ Aggregate Unpaid Principal Amount ” on the Grid Schedule of Loans attached to and forming part of this Note, together with all accrued and unpaid interest thereon calculated with respect to each advance hereunder from and including the date of such advance at the interest rate set forth below in Section 3 (“ Interest ”), on or before June 30, 2020 (the “ Maturity Date ”) or such other earlier date as this Note is required or permitted to be repaid as provided hereunder; provided that the Aggregate Unpaid Principal Amount shall not exceed the Maximum Principal Amount specified below. The aggregate Principal Amount of this Note shall not exceed $[1,100,000.00]/[900,000.00] (“ Maximum Principal Amount ”). As of the Issuance Date, the Aggregate Unpaid Principal Amount of this Note is $[784,612]/[630,837].

 

This Note is being issued pursuant to the Exchange Agreement (as defined below) between the Borrower and the original Holder of the Note. By its acceptance of this Note, Holder agrees to be bound by the terms of the Exchange Agreement. Payment of Principal and Interest of this Note shall be secured in accordance with the Security Agreement (defined below). This Note ranks pari passu in right of payment with all other notes issued pursuant to the Exchange Agreement and the Prior Senior Notes (as defined below) that remain outstanding as of the Issuance Date, under the terms set forth herein and shall be senior in right of payment to all other Indebtedness of the Borrower and its Subsidiaries, subject to the terms, conditions and limitations set forth herein. This Note is subject to the following additional provisions:

 

Section 1. Definitions . For the purposes hereof, in addition to the terms defined elsewhere in this Note, (a) capitalized terms not otherwise defined herein shall have the meanings set forth in the Exchange Agreement and (b) the following terms shall have the following meanings:

 

Business Day ” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Common Stock ” means the common stock of the Borrower, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Common Stock Equivalents ” means any securities of the Borrower which entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

 

 

 

Event of Default ” shall have the meaning set forth in Section  6 (a) .

 

Exchange Agreement ” means that certain Exchange Agreement, dated as of July 19, 2018 by and between the Borrower and the original Holder as amended, modified or supplemented from time to time in accordance with its terms.

 

Indebtedness ” shall have the meaning ascribed to such term in the Security Agreement.

 

Majority in Interest ” means, at any time of determination, fifty-one percent (51%) in interest (based on then-outstanding aggregate Principal Amounts of the Notes issued under the Exchange Agreement at the time of such determination) of the holders of such Notes.

 

Permitted Indebtedness ” shall have the meaning ascribed to such term in the Security Agreement.

 

Permitted Lien s ” shall have the meaning ascribed to such term in the Security Agreement.

 

Prior Senior Notes ” means the aggregate principal amount of (i) $2,545,199 of Senior Secured Convertible Notes originally issued pursuant to that certain exchange agreement, dated March 20, 2017 and (ii) $504,452 of Senior Secured Convertible Notes originally issued pursuant to that certain exchange agreement, dated March 27, 2018.

 

Securities Act ” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Security Agreement ” means that certain Amended and Restated Security Agreement dated as of March 20, 2017, as amended on March 27, 2018 and on the date hereof, which agreement provides for the inclusion of the Note as a secured note under the terms thereof.

 

Transaction Documents ” means this Note, together with the Exchange Agreement, the Security Agreement and all other Notes, agreements, instruments, documents and certificates executed in connection with the Exchange Agreement or contemplated thereby.

 

Section 2 . Extensions of Credit . This Note is a direct obligation of the Borrower and evidences a loan presently being made by the Lender (as specified on the Grid Schedule of Loans) to the Borrower, and at the Borrower’s election, which may be made following the Issuance Date but prior to the Maturity Date, (each, a “ Loan ”) from time to time by the Lender, to the Borrower up to the Maximum Principal Amount. The Borrower may borrow, pay, prepay and re-borrow any portion of the Maximum Principal Amount available under this Note up to and including the first to occur of the Maturity Date or the date of an Event of Default (as defined in Section 6 below). The Borrower shall give the Lender notice of each borrowing request by 2:00 p.m. (New York City time) at least two (2) Business Days prior to each requested borrowing hereunder, provided that no loan advance shall be in an amount equal to less than $10,000. Lender shall make all loan advances hereunder promptly after its receipt of such request in accordance with instructions provided by Borrower, but in no event later than two (2) Business Days following the date of such loan request.

 

The Aggregate Unpaid Principal Amount due hereunder may be reduced to zero from time to time without affecting the validity of this Note. Notwithstanding the foregoing, however, this Note may be earlier terminated in full upon repayment by the Borrower of the Aggregate Unpaid Principal Amount and Interest thereon, if the Borrower expressly notified the Lender that upon such repayment it elects to terminate its rights to obtain further loans hereunder, in which event no further loans shall be available to the Borrower hereunder.

 

2

 

 

The amounts outstanding from time to time under this Note as evidenced on the Grid Schedule of Loans attached hereto shall, when endorsed by Lender, be conclusive and binding on the Borrower in the absence of manifest error; provided that the failure of the Lender to record any amounts owing hereunder on the Grid Schedule of Loans attached hereto shall not affect the obligation of the Borrower to pay to the Lender the Aggregate Unpaid Principal Amount due and payable hereunder at such time or times that payment is due. The Lender shall and is hereby authorized by the Borrower to endorse on the attached Grid Schedule of Loans an appropriate notation to evidence the date and Principal Amount of each Loan made to the Borrower by the Lender. The Lender’s failure to make (or any error in making) any such notation shall not limit or otherwise affect the obligations of the Borrower hereunder. This Note shall be used to record all Loan advances and payments of Principal hereunder and it shall continue to be used even though there may be periods when no amount of Principal or Interest is owing hereunder. The Grid Schedule of Loans shall be updated: (i) from time to time to reflect each advance of Principal; and (ii) monthly within 10 days of the end of each calendar month to reflect accrued Interest payable by Borrower.

 

Section 3 . Interest . This Note shall bear and accrue simple Interest at the rate of 7.5% per annum of the Aggregate Unpaid Principal Amount, payable in arrears on the Maturity Date or such earlier date as this Note may be payable in accordance with Section 4 , below, at which time all accrued and unpaid Interest shall be immediately due and payable. All computations of Interest payable hereunder shall be on the basis of a 365-day year and actual days elapsed in the period for which such Interest is payable. Accrued Interest on the Aggregate Unpaid Principal Amount shall be due and payable on the Maturity Date or on any earlier date on which the Aggregate Unpaid Principal Amount of this Note becomes due and payable.

 

Section 4 . Payment . Payment of the Aggregate Unpaid Principal Amount of this Note, and Interest thereon (the “ Unpaid Balance ”), shall be due and payable in full on the Maturity Date and be made upon the surrender of this Note to the Borrower, at its chief executive office (or such other office within the United States as shall be designated by the Borrower to the Holder hereof) (the “ Designated Office ”), in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts. The Unpaid Balance of this Note at any time shall be the total amount advanced by the Lender to Borrower, less the total payments of Principal Amount and accrued Interest previously made hereon by Borrower.

 

If the Maturity Date (or earlier date of payment) shall be a Saturday or a Sunday or shall be a legal holiday in the State of New York, then such action may be taken or such right may be exercised on the next succeeding day not a legal holiday and Interest shall continue to accrue on any Principal Amount so effected until the payment thereof on such extended due date. The Borrower may prepay this obligation in whole or part at any time and from time to time without premium or penalty of any kind, upon ten (10) days advance written notice to the Lender, provided that any prepayment shall be applied first to accrued but unpaid Interest and any other sums owed to Lender, and then to reduce the unpaid Principal Amount of the Note. Payments of Principal Amount and Interest shall be deemed made on the date such payment is deposited or, if mailed, on the date deposited in the mail with proper postage and addressed to the Lender and the address as shown on the records of the Borrower, or such other address as provided to the Borrower in writing by the Lender. Payments of all amounts due hereunder shall be made in lawful money of the United States by check or wire transfer of immediately available funds to such account as designated by Lender in advance of the subject payment date.

 

3

 

 

Section 5 .     Seniority , Security and Negative Covenants .

 

(a)       Seniority and Security . This Note ranks pari passu in right of payment with (i) the Prior Senior Notes that remain outstanding as of the Issuance Date and (ii) all other Notes now or hereafter issued in accordance with the Exchange Agreement and shall be senior in right of payment to all other Indebtedness of the Borrower and its subsidiaries, subject to the terms herein. The obligations of the Borrower under this Note are secured by certain assets of the Borrower pursuant to the Security Agreement.

 

(b)         Negative Covenants . As long as any portion of this Note remains outstanding, unless the holders of a Majority in Interest shall have otherwise given prior written consent, the Borrower shall not, and shall not permit any of the Subsidiaries to, directly or indirectly:

 

(i)      other than Permitted Indebtedness (as defined in the Security Agreement), enter into, create, incur, assume, guarantee or suffer to exist any Indebtedness for borrowed money of any kind, including, but not limited to, a guarantee, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom;

 

(ii)     other than Permitted Liens (as defined in the Security Agreement), enter into, create, incur, assume or suffer to exist any Liens (as defined in the Security Agreement) of any kind, on or with respect to any of its property or assets now owned or hereafter acquired or any interest therein or any income or profits therefrom; or

 

(iii)    repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its Common Stock or Common Stock Equivalents other than as to (x) repurchases of Common Stock or Common Stock Equivalents pursuant to employee, director or consultant repurchase plans or similar agreements; and (y) repurchases of Common Stock or Common Stock Equivalents of any claims asserted or threatened by holders of such securities; or

 

(iv)    prepay any Indebtedness (as defined in the Security Agreement), other than the Notes if on a pro-rata basis, and other than pursuant to payments of Permitted Indebtedness. For purposes of clarity, nothing herein shall restrict or limit the Borrower’s payment of the principal amount of, or interest on, any instruments evidencing Indebtedness issued by the Borrower prior to the date hereof and as such instruments may have been amended to date, in accordance with their terms, and any deferrals, renewals or extensions thereof, and any notes or other instruments or evidences of Indebtedness issued in respect of or in exchange thereof. 

 

(c)      Notwithstanding the foregoing provisions of this Section 5 , if any transaction contemplated by Section 5 (b) provides for the repayment of this Note at or prior to the closing of such transaction, then the consent of the Lender shall not be required, provided that this Note is paid in full at or prior to the closing of such transaction.

 

Section 6 . Events of Default .

 

(a)      For purposes of this Note, an “ Event of Default ” means, wherever used herein, any of the following events (whatever the reason for such event and whether such event shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

(i)     the Borrower’s or any subsidiary of the Borrower’s (a “ Subsidiary ”) failure to pay to the Lender any amount of Principal, Interest, late charges or other amounts when and as due under this Note (including, without limitation, the Borrower’s or any Subsidiary’s failure to pay any redemption payments or amounts hereunder) or any other Transaction Document or any other agreement, document, certificate or other instrument delivered in connection with the transactions contemplated hereby and thereby, except, in the case of a failure to pay Interest, late charges or other amounts when and as due, in which case only if such failure remains uncured for a period of at least fifteen (15) days;

 

4

 

 

(ii)      the occurrence of any default under, redemption of or acceleration prior to maturity of any Indebtedness of the Borrower or any of its Subsidiaries, other than in any amount not in excess of an aggregate of $150,000;

 

(iii)     bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against the Borrower or any Subsidiary and, if instituted against the Borrower or any Subsidiary by a third party, shall not be dismissed within sixty (60) days of their initiation;

 

(iv)     the commencement by the Borrower or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the filing by it of a petition seeking reorganization or relief under any applicable federal, state or foreign law, or the making by it of an assignment for the benefit of creditors, or the execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission by it in writing of its inability to pay its debts generally as they become due, or the taking of corporate action by the Borrower or any Subsidiary in furtherance of any such action;

 

(v)     the entry by a court of (i) a decree, order, judgment or other similar document in respect of the Borrower or any Subsidiary of a voluntary or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or (ii) a decree, order, judgment or other similar document adjudging the Borrower or any Subsidiary as bankrupt or insolvent, or approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect of the Borrower or any Subsidiary under any applicable federal, state or foreign law or (iii) a decree, order, judgment or other similar document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Borrower or any Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed and in effect for a period of sixty (60) consecutive days;

 

(vi)     a final judgment or judgments for the payment of money aggregating in excess of $150,000 are rendered against the Borrower and/or any of its Subsidiaries and which judgments are not, within forty-five (45) days after the entry thereof, bonded, discharged or stayed pending appeal, or are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which is covered by insurance or an indemnity from a credit worthy party shall not be included in calculating the $150,000 amount set forth above so long as the Borrower provides the Lender a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory to the Lender) to the effect that such judgment is covered by insurance or an indemnity and the Borrower or such Subsidiary (as the case may be) will receive the proceeds of such insurance or indemnity within forty-five (45) days of the issuance of such judgment;

 

5

 

 

(vii)   the Borrower and/or any Subsidiary, individually or in the aggregate, either (i) fails to pay, when due, or within any applicable grace period, any payment with respect to any Indebtedness in excess of $150,000 due to any third party (other than, with respect to unsecured Indebtedness only, payments contested by the Borrower and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation of any agreement for monies owed or owing in an amount in excess of $150,000, which breach or violation permits the other party thereto to declare a default or otherwise accelerate amounts due thereunder, or (ii) suffer to exist any other circumstance or event that would, with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding the Borrower or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business, assets, operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects of the Borrower or any of its Subsidiaries, individually or in the aggregate;

 

(viii)   other than as specifically set forth in another clause of this Section 6 (a) , the Borrower or any Subsidiary breaches, in any material respect, any representation, warranty, covenant or other term or condition of any Transaction Document (including, without limitation, the Security Agreement, except, in the case of a breach of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of ten (10) consecutive Business Days after notice of breach from Lender or fifteen (15) consecutive Business Days from when the Borrower became aware of such breach (in each case, subject to any grace or cure period provided therein);

 

(ix)     any material provision of any Transaction Document (including, without limitation, the Security Agreement) shall at any time for any reason (other than pursuant to the express terms thereof or such provision has been performed in full or waived by the relevant party) cease to be valid and binding on or enforceable against the parties thereto, or a proceeding shall be commenced by the Borrower or any Subsidiary or any governmental authority having jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof, or the Borrower or any Subsidiary shall deny in writing that it has any liability or obligation purported to be created under any Transaction Document;

 

(x)      the Security Agreement shall for any reason fail or cease to create a separate valid and perfected and, except to the extent permitted by the terms hereof or thereof, first priority Lien on the Collateral (as defined in the Security Agreement) in favor of the Lender; or

 

(xi)    any material damage to, or loss, theft or destruction of, any material portion of the Collateral, whether or not insured, which causes, for more than thirty (30) consecutive days, the cessation or substantial curtailment of revenue producing activities at any facility of the Borrower or any Subsidiary, if any such event or circumstance could have a Material Adverse Effect.

 

(b)            Remedies upon Event of Default .

 

(i)     If an Event of Default (other than an Event of Default arising from events described in clauses (iii), (iv) and/or (v) of Section 6 (a) ) occurs and is continuing with respect to any of the Notes, the Lender may declare all of the then outstanding Principal Amount of this Note and all other Notes held by the Lender, including any Interest to the date of payment. Upon a declaration of acceleration, such Principal Amount and premium, if any, and accrued and unpaid Interest, to the date of payment shall be immediately due and payable. Upon the occurrence of an Event of Default arising from events described in clauses (iii), (iv) and/or (v) of Section 6 (a) , this Note shall become due and payable automatically, without any declaration or other act on the part of the Lender. In the event of such acceleration, the amount due and owing to the Lender shall be 110% of the outstanding Principal Amount of the Notes held by the Lender (plus all accrued and unpaid Interest and late charges, if any). The Borrower hereby, to the fullest extent permitted by applicable law, waives presentment, demand, or any other notice of any other kind (except as otherwise specifically set forth herein), in connection with performance, default, acceleration or enforcement of or under this Note.

 

6

 

 

(ii)     If an Event of Default with respect to this Note occurs and is continuing, the Lender may pursue any available remedy by proceeding at law or in equity to collect the defaulted payment or to enforce the performance of any provision of this Note. Notwithstanding any other provision in this Note, the Lender of this Note shall have the right, which is absolute and unconditional, to receive payment of the Principal Amount, plus accrued and unpaid Interest thereon, in respect of the Note held by the Lender, on or after the final Maturity Date, or to bring suit for the enforcement of any such payment on or after such date, and such rights shall not be impaired or affected adversely without the consent of the Lender.

 

(iii)     Except as otherwise provided herein, no right or remedy conferred in this Note upon the Lender is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy. No delay or omission of the Lender of this Note to exercise any right or remedy accruing upon any Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or any acquiescence therein. Every right and remedy given by this Section 6 or by law to the Lender may be exercised from time to time, and as often as may be deemed expedient, by the Lender.

 

Section 7 .     Transferability; Loss and Replacement .

 

(a)     This Note has not been registered under the Securities Act, or the securities laws of any state or other jurisdiction.  Neither this Note nor any interest or participation herein may be reoffered, sold, assigned, transferred, pledged, encumbered or otherwise disposed of (a “ Transfer ”) in the absence of registration under the Securities Act and any applicable state securities laws, or unless (i) such transaction is exempt from, or not subject to, registration under the Securities Act or the securities laws of any state or other jurisdiction and (ii) is made in compliance with applicable federal and state statutory resale restrictions, if any.  The Holder by its acceptance of this Note agrees that it shall not offer, sell, assign, transfer, pledge, encumber or otherwise dispose of this Note or any portion thereof or interest therein without the prior written consent of Borrower except to a Permitted Transferee and then only: (a) to a Person it reasonably believes to be an “accredited investor” within the meaning of Rule 501(a) under the Securities Act, or (b) pursuant to a transaction in compliance with Rule 144 or Rule 144A under the Securities Act, and in each case the transferor shall furnish the Borrower with such certifications, legal opinions or other information as the Borrower may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act as applicable. For the purposes of this Note, a “Permitted Transferee” is an Affiliate of the Lender.

 

(b)     This Note has been issued subject to certain investment representations of the original Holder set forth in the Exchange Agreement and may be transferred or exchanged only in compliance with the Exchange Agreement and applicable federal and state securities laws and regulations.

 

(c)       Reliance on Note Register . The Transfer of this Note is registrable on the books of the Borrower upon surrender of this Note for registration of Transfer at the Borrower’s designated office, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Borrower duly executed by, the Holder hereof or such Holder’s attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate Principal Amount, will be issued to the designated transferee or transferees. Prior to due presentment for transfer to the Borrower of this Note, the Borrower and any agent of the Borrower may treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Borrower nor any such agent shall be affected by notice to the contrary.

 

7

 

 

(d)       Transfer Mechanics . Upon presentation of this Note for registration of Transfer at the Borrower’s designated office accompanied by (i) certification by the transferor that such Transfer is in compliance with the terms hereof, (ii) a legal opinion or other information as the Borrower may reasonably request to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act, as applicable, and (iii) by a written instrument of Transfer in a form approved by the Borrower executed by the Holder, in person or by the Holder’s attorney thereunto duly authorized in writing, and including the name, address and telephone and fax numbers of the transferee and name of the contact person of the transferee, such Note shall be transferred on the Note register, and a new Note of like tenor and bearing the same legends shall be issued in the name of the transferee and sent to the transferee at the address and c/o the contact person so indicated. Transfers and exchanges of Notes shall be subject to such additional restrictions as are set forth in the legends on the Notes and to such additional reasonable regulations as may be prescribed by the Borrower as specified herein. Successive registrations of Transfers as aforesaid may be made from time to time as desired, and each such registration shall be noted on the Note register.

 

Section 8 .        Miscellaneous .

 

(a)      Notices . Any and all notices or other communications or deliveries to be provided by the Holder hereunder, shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service, addressed to the Borrower, at the address set forth above, or such other facsimile number or address as the Borrower may specify for such purposes by notice to the Holder delivered in accordance with this Section  8 (a) . Any and all notices or other communications or deliveries to be provided by the Borrower hereunder shall be in writing and delivered personally, by facsimile, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number or address of the Holder appearing on the books of the Borrower, or if no such facsimile number or address appears on the books of the Borrower, at the principal place of business of such Holder, as set forth in the Exchange Agreement. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 5:30 p.m. (New York City time) on any date, (ii) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, (iii) the second Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (iv) upon actual receipt by the party to whom such notice is required to be given.

 

(b)       Absolute Obligation . Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Borrower, which is absolute and unconditional, to pay the unpaid Principal Amount of, liquidated damages and accrued Interest, as applicable, on this Note at the time, place, and rate, and in the coin or currency, herein prescribed. This Note is a direct debt obligation of the Borrower.

 

(c)      Lost or Mutilated Note . If this Note shall be mutilated, lost, stolen or destroyed, the Borrower shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen or destroyed Note, a new Note identical in all respects to this Note for the Note so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such Note, and of the ownership hereof, reasonably satisfactory to the Borrower.

 

8

 

 

(d)       Governing Law . All questions concerning the construction, validity, enforcement and interpretation of this Note shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Note or any of the Transaction Documents (whether brought against a party hereto or its respective Affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (unless the Delaware Court of Chancery shall decline to accept jurisdiction over a particular matter, in which case, in any Delaware state or federal court within the State of Delaware) (such courts, collectively, the “ Delaware Courts ”). Borrower and Holder hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts, or such Delaware Courts are improper or inconvenient venue for such proceeding. Each of Borrower and Holder hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Borrower and Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Note or the transactions contemplated hereby.

 

(e)       Waiver . Any waiver by the Borrower or the Lender of a breach of any provision of this Note shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Note. The failure of the Borrower or the Lender to insist upon strict adherence to any term of this Note on one or more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Note on any other occasion. Any waiver by the Borrower or the Lender must be in writing.

 

(f)       Severability ; Usury . If any provision of this Note is invalid, illegal or unenforceable, the balance of this Note shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any Interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of Interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law and the interest payable shall be computed at such maximum rate. Any prior Interest payments in excess of such maximum rate shall be applied and shall be deemed to have been payments in reduction of the Aggregate Unpaid Principal Amount of this Note.

 

(g)       Independent Representation . Each Holder expressly represents and warrants to the Borrower that (a) said Holder has had the opportunity to seek the advice of his or its own counsel and advisors; (b) this Agreement is the result of arm’s length negotiations conducted by and among the parties; and (c) said Holder acknowledges that the law firm of Becker & Poliakoff, LLP has been retained by the Borrower to prepare this Agreement as legal counsel for the Borrower, that Becker & Poliakoff, LLP does not represent any Holder in connection with the preparation or execution of this Agreement, that such firm has not given any legal, investment or tax advice to any Holder regarding this Agreement, and that such Holder has not relied upon any legal advice except as provided by its own attorneys. Becker & Poliakoff, LLP is expressly intended as a beneficiary of the representations and warranties of the Holder contained in this Section 8(g) .

 

(h)      Entire Agreement; Amendments . This Note and the other Transaction Documents are intended by the parties as the final, complete and exclusive statement of the transactions evidenced thereby. All prior or contemporaneous promises, agreements and understandings, whether oral or written, are deemed to be superseded by this Note and such other Transaction Documents, and no party is relying on any promise, agreement or understanding not set forth in this Note or such other Transaction Documents. Neither this Note nor any term hereof may be amended unless such amendment is in a writing executed by the Borrower and the Holder.

 

9

 

 

(i)       Invalidated Payments . To the extent that Lender receives any payment on account of any of Borrower’s obligations under this Note, and any such payment(s) or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, subordinate and/or required to be repaid to a trustee, receiver or any other person or entity under any bankruptcy act, state or federal law, common law or equitable cause, then, to the extent of such payment(s) received, the Borrower’s obligations or part thereof intended to be satisfied shall be revived and continue in full force and effect, as if such payment(s) had not been received by the Lender and applied on account of Borrower’s obligations.

 

(j)       Next Business Day . Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day.

 

(k)       Headings . The headings contained herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof.

 

 

[ Signature Page Follows ]

 

10

 

 

IN WITNESS WHEREOF, the Borrower has caused this Note to be executed as of the Issuance Date.

 

BORROWER:

 

AEON GLOBAL HEALTH CORP.

 

 

By: _________________________________

Name:   Michael J. Poelking

Title:     Chief Financial Officer

 

 

Agreed and received:

 

[HANIF A. ROSHAN]/[OPTIMUM VENTURES LLC]

 

 

 

By: _____________________________

Name:  

Title:  

 

 

 

 

 

 

 

[GRID SCHEDULE OF LOANS FOLLOWS]

 

 

 

11

 

 

GRID SCHEDULE OF LOANS

 

The Grid Schedule of Loans set forth below is the “Grid” referred to in, and forming part of, the Senior Secured Grid Note dated as of July 19, 2018, and recording Loan Advances made by the Lender to Aeon Global Health Corp.

 

Date of Loan

Advance

Amount

of Loan

Aggregate Unpaid

Principal Amount Repaid

Aggregate Unpaid

Principal Amount

Amount of

Accrued Interest

Notation

7/19/2018

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
 

$

$

$

$

 
           
           
           
           
           
           
           
           

TOTAL

$

$

$

$

 

 

12

  Exhibit 10.1

 

 

EACH FORMER MEMBER EXECUTING THIS AGREEMENT IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT. BY SIGNING THIS AGREEMENT AND RELEASE, YOU GIVE UP AND WAIVE IMPORTANT LEGAL RIGHTS.

 

SETTLEMENT AND RESTRUCTURING AGREEMENT

 

This Settlement and Restructuring Agreement (the “ Agreement ”) is made as of the 19 th day of July, 2018 (the “ E xecution Date ”) by and among Aeon Global Health Corp. (formerly, Authentidate Holding Corp.) a Delaware corporation, (the “ Company ”), Peachstate Health Management, LLC d/b/a AEON Clinical Laboratories, a Georgia limited liability company (“ Peachstate ”), and each of the former members of Peachstate included on the signature pages hereto (the “ Former Members ”). The Company, Peachstate and the Former Members may collectively be referred to as the “ Parties ” throughout this Agreement.

 

W I T N E S S E T H:

 

WHEREAS, the Company, Peachstate, and RMS Merger Sub LLC entered into that certain Amended and Restated Agreement and Plan of Merger dated as of January 26, 2016, and as subsequently amended as of May 31, 2016 and December 15, 2016 (together, the “ Merger Agreement ”) pursuant to which Peachstate merged with and into RMS Merger Sub LLC and became a wholly-owned subsidiary of the Company effective upon the closing of the transactions contemplated by the Merger Agreement, which occurred on January 27, 2016 (the “ Merger ”); and

 

WHEREAS, pursuant to the Merger Agreement, the Former Members would receive certain contingent consideration based on the achievement of EBITDA targets by Peachstate (the “ Earnout ”); and

 

WHEREAS, the Former Members are all of the former members of Peachstate entitled to receive the Earnout under the Merger Agreement; and

 

WHEREAS, the Merger Agreement provided that the Earnout targets would automatically be adjusted in the event of changes to the reimbursement rates set by the Centers for Medicare and Medicaid Services (“ CMS ”) for the services provided by Peachstate; and

 

WHEREAS, the Merger Agreement provided that upon achievement of the EBITDA target for the three calendar years ending December 31, 2016, 2017 and 2018 (“ 2018 Earnout ”), the Former Members would be issued such number of shares of the Company’s Common Stock so that the total number of shares of the Company’s Common Stock issued to the Former Members pursuant to the Merger Agreement would equal 85% of the issued and outstanding shares of the Company’s Common Stock on a post-issuance and Fully Diluted (as defined in the Merger Agreement) basis; and

 

WHEREAS, the Merger Agreement provided that upon achievement of the EBITDA target for the four calendar years ending December 31, 2016, 2017, 2018 and 2019 (“ 2019 Earnout ”), the Former Members would receive such number of additional shares of the Company’s Common Stock so that the total number of shares of the Company’s Common Stock issued to the Former Members pursuant to the Merger Agreement would equal 90% of the issued and outstanding shares of the Company’s Common Stock on a post-issuance and Fully Diluted (as defined in the Merger Agreement) basis; and

 

 

 

 

WHEREAS, pursuant to a Registration Rights Agreement entered into contemporaneously with the Merger Agreement (the “ Registration Rights Agreement ”), the Former Members were granted certain registration rights to have the Common Stock of the Company that was issued to them pursuant to the Merger Agreement registered for resale under the Securities Act of 1933, as amended, which rights remain outstanding; and

 

WHEREAS, subsequent to the closing of the Merger, the Parties expressed differences of opinion on the interpretation of certain provisions of the Merger Agreement, including the number of shares of Common Stock issued under the Merger Agreement and the calculations required by the adjustment mechanism of the Earnout, as well as the assumption of income tax liabilities on account of the Merger; and

 

WHEREAS, due to the financial performance of the Company, certain of the Former Members have provided loans to the Company in the aggregate amount of approximately $1,351,482, including accrued interest (collectively the “ Loans ”), which Loans have been extended on multiple occasions; and

 

WHEREAS, the Parties to this Agreement wish to reach a full and final resolution of all disagreements among them.

 

NOW, THEREFORE , in consideration of the above and the mutual warranties, representations, covenants, and agreements set forth herein, the Parties agree as follows:

 

1.       Recitals.      

 

The recitals set forth above are incorporated herein by reference as part of this Agreement among the Parties.

 

2.       Definitions.

 

In addition to the terms defined elsewhere in this Agreement capitalized terms that are not otherwise defined herein shall have the meanings given to such terms as set forth in this Section 2:

 

Affiliate ” of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person.  For the purposes of this definition, “control”, when used with respect to any specified Person, means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

 

Business Day ” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Commission ” means the United States Securities and Exchange Commission.

 

Common Stock ” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Credit Agreement ” shall have the meaning ascribed to such term in Section 4 of this Agreement.

 

EBITDA ” shall have the meaning ascribed to such term in the Merger Agreement.

 

Effective Date ” shall have the meaning ascribed to such term in Section 3 of this Agreement.

 

2

 

 

Lender(s) ” shall have the meaning ascribed to such term in Section 4 of this Agreement.

 

Person ” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Securities Act ” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Senior Notes ” means those certain senior secured convertible notes, in the aggregate principal amount of $3,049,651, of which the aggregate principal amount of $2,545,199 was originally issued by the Company on March 20, 2017 and the aggregate principal amount of $504,452 was originally issued by the Company on March 27, 2018, in each case as such senior notes have been amended to date.

 

Trading Day ” means a day on which the principal Trading Market is open for trading.

 

Trading Market ” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE MKT, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange, or any tier of the OTC Markets Inc. (or any successors to any of the foregoing).

 

Transaction Documents ” means this Agreement, Credit Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

3.      Effective Date of Agreement.

 

The Effective Date of this Agreement (the “ Effective Date ”) shall be the day upon which the following conditions shall have occurred:

 

(i)      the delivery by each Former Member and Peachstate to the Company of a signed copy of this Agreement;

 

(ii)     the delivery by the Company to Peachstate and each Former Member of a copy of this Agreement executed by an executive officer of the Company; and

 

(iii)    the execution and delivery by the Lenders and the Company of (a) the Credit Agreement contemplated by Section 4 of this Agreement and (b) any ancillary agreements described in such Credit Agreement.

 

4.      Restructuring of Loans .

 

Contemporaneously with, and as a condition precedent to the effectiveness of this Agreement, Hanif A. Roshan and Optimum Ventures, LLC (the “ Lenders ”) shall enter into an agreement with the Company to exchange the existing Senior Notes previously issued by the Company to such Lenders for a new senior credit instrument (the “ Credit Agreement ”) pursuant to which the Lenders shall agree to provide up to $2.0 million of credit to the Company, inclusive of the current principal amount of, and accrued interest on, the Loans evidenced by the Senior Notes held by the Lenders. The Parties agree that the Credit Agreement shall: (i) be in the form of the agreement annexed hereto as Exhibit A ; (ii) be a senior secured credit facility, on a parity basis with the Senior Notes held by the other holders of the outstanding Senior Notes; (iii) bear interest at the rate of 7.5% per annum; and (iv) be due and payable in full on June 30, 2020, or earlier at the option of the Company.

 

3

 

 

5.        Issuance of Additional Common Stock.

 

In consideration of the restructuring of the consideration due to the Former Members under the Merger Agreement, the Company shall issue to the Former Members an aggregate of 2,500,000 shares of the Company’s Common Stock (the “ Additional Shares ”). The Additional Shares shall be issued to the Former Members pro rata based on their respective percentage ownership of Peachstate prior to the Merger and shall be deemed earned and issued on February 28, 2019. The Additional Shares shall be “restricted securities” within the meaning of Rule 144 promulgated by the Securities and Exchange Commission and shall bear the restrictive legend set forth in Section 14(e) of this Agreement.

 

6.        Adjustments to Earnout s .

 

a.      Adjustments to 2018 Earnout . The Parties hereby agree that the 2018 Earnout target, as adjusted pursuant to the Merger Agreement, shall be $21,483,749 of EBITDA for the three calendar years ending December 31, 2018 (the “ 2018 Earnout Target ”). In the event the 2018 Earnout Target is achieved, then on October 1, 2019, subject to the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2018, the Company shall issue to the Former Members a fixed amount of 3,000,000 shares of the Company’s Common Stock (the “ 2018 Maximum Earnout Shares ”). In the event that Peachstate fails to achieve the 2018 Earnout Target, but achieves EBITDA for the three calendar years ending December 31, 2018 of at least 75% of the 2018 Earnout Target (the “ Reduced 2018 Earnout Target ”), then on October 1, 2019, subject to the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2018, the Company shall issue to the Former Members a fixed amount of 2,250,000 shares of the Company’s Common Stock (the “ 2018 Reduced Earnout Shares ”).

 

b.      Adjustments to 2019 Earnout . The Parties hereby agree that the 2019 Earnout target, as adjusted pursuant to the Merger Agreement, shall be $32,600,530 of EBITDA for the four calendar years ending December 31, 2019 (the “ 2019 Earnout Target ”). In the event the 2019 Earnout Target is achieved, then regardless of whether the 2018 Earnout Target is achieved, within three (3) Business Days following the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2019, the Company shall issue to the Former Members a fixed amount of 4,000,000 shares of the Company’s Common Stock (the “ 2019 Maximum Earnout Shares ”). In the event that Peachstate fails to achieve the 2019 Earnout Target, but achieves EBITDA for the four calendar years ending December 31, 2019 of at least 75% of the 2019 Earnout Target (the “ Reduced 2019 Earnout Target ”), then within three (3) Business Days following the completion of the audited financial statements of Peachstate for the calendar year ending December 31, 2019, the Company shall issue to the Former Members a fixed amount of 3,000,000 shares of the Company’s Common Stock (the “ 201 9 Reduced Earnout Shares ”).

 

c.      The Former Members hereby agree that as of the Effective Date, the arrangements set forth in this Agreement supersede in all respects the Parties’ respective rights and obligations for the issuance of any and all additional shares of Common Stock pursuant to the Merger Agreement.

 

4

 

 

d.     The Parties further agree that in the event Peachstate fails to achieve the 2018 Earnout Target or the Reduced 2018 Earnout Target, but exceeds the 2019 Earnout Target, then the amount by which Peachstate exceeded the 2019 Earnout Target (the “ Earnout Credit ”) shall be credited to the 2018 Earnout Target or the Reduced 2018 Earnout Target. In such an event, the Earnout Credit shall be added to the amount of EBITDA achieved for the three calendar years ending December 31, 2018, and the number of shares of Common Stock which may be earned by the Former Members shall be recomputed. If the addition of the Earnout Credit to the EBITDA actually achieved by Peachstate for the requisite period results in Peachstate achieving the 2018 Earnout Target or the Reduced 2018 Earnout Target, as the case may be, then such number of additional shares of Common Stock shall be issued to the Former Members as may be allocated to them based on the achievement of either the 2018 Earnout Target or Reduced 2018 Earnout Target. The issuance of any additional shares of Common Stock to the Former Members pursuant to this mechanism would be in addition to the issuance to the Former Members of the 2019 Maximum Earnout Shares.

 

e.       For purposes of clarity, the following examples shall illustrate the Parties’ agreement as to the manner in which the Earnout Credit shall operate:

 

i.       If Peachstate did not initially achieve the Reduced 2018 Earnout Target, but was entitled to an Earnout Credit in an amount that when added to the amount actually achieved for the requisite period is sufficient for it to achieve the Reduced 2018 Earnout Target, then the Former Members would only receive all of the 2018 Reduced Earnout Shares (2,250,000 shares);

 

ii.      If Peachstate did not initially achieve the Reduced 2018 Earnout Target, but was entitled to an Earnout Credit in an amount that when added to the amount actually achieved for the requisite period is sufficient for it to achieve the maximum 2018 Earnout Target, then the Former Members would only receive all of the 2018 Maximum Earnout Shares (3,000,000 shares);

 

iii.     If Peachstate initially achieved the Reduced 2018 Earnout Target, but not the maximum 2018 Earnout Target, and was entitled to an Earnout Credit in an amount that when added to the amount actually achieved for the requisite period is sufficient for it to achieve the maximum 2018 Earnout Target, then the Former Members would receive an additional 750,000 shares of Common Stock.

 

7.      Waiver of Certain Right s .

 

Each of the Former Members, on their own behalf and on behalf of all current and future holders of each of their respective Registrable Securities (as defined in the Registration Rights Agreement), hereby irrevocably waives any and all registration rights now existing or arising under the Registration Rights Agreement and all notice and other rights related thereto. Each Former Member hereby acknowledges and agrees that it shall not commence or prosecute in any way, or cause to be commenced or prosecuted, any action in any court relating to such rights under the Registration Rights Agreement. The Parties further agree to forever waive those covenants and other agreements of the Merger Agreement for which performance may occur after the Closing Date of the Merger, other than the covenants and agreements in Sections 7.6, 7.12 and 7.13 of the Merger Agreement.

 

8.      Release of the Company .

 

Upon the Effective Date of this Agreement, and in return for valuable consideration, the receipt of which is hereby acknowledged, Peachstate and the Former Members, on behalf of themselves, and for all persons who may claim by, through, or under them, their present and former representatives, agents, attorneys, predecessors, successors, insurers, partners, administrators, heirs, executors and assigns (hereinafter referred to as the “ Peach Releasors ”), release and forever discharge the Company, and all of their predecessors, subsidiaries, affiliates, parent corporations, and all of their respective, present or past officers, agents, employees, shareholders, directors, attorneys, insurers, sureties, successors and assigns, as well as any employee or former employee thereof (individually and collectively hereinafter referred to as the “ Company Parties ”), from any and all rights, claims and causes of action, suits, liabilities, obligations, debts, dues, sums of money, accounts, reckonings, bonds, bills, covenants, contracts, controversies, agreements, promises, damages, judgments, executions, claims and demands, in law or equity, known or unknown, which, against the Company Parties, the Peach Releasors have, had or may have from the beginning of time through the Effective Date of this Agreement, arising out of or related to, directly or indirectly, the Merger and/or the Merger Agreement, including, but not limited to, claims arising under all federal, state and local statutes, laws and ordinances prohibiting, without limitation, breach of contract, breach of the covenant of good faith and fair dealing, breach of fiduciary duty, defamation or fraud and any alleged entitlement to costs fees, or expenses, including attorneys’ fees’; provided however, that the foregoing release (i) shall exclude any claims for breach of obligations under this Agreement and (ii) shall not be construed as releasing the Company from its obligations under the Senior Notes held by the Lenders or the Credit Agreement contemplated by Section 4 of this Agreement.

 

5

 

 

9.      Release of Peachstate and Former Members .     

 

Upon the Effective Date of this Agreement, and in return for valuable consideration, the receipt of which is hereby acknowledged, the Company Parties release and forever discharge the Peach Releasors, from any and all rights, claims and causes of action, suits, liabilities, obligations, debts, dues, sums of money, accounts, reckonings, bonds, bills, covenants, contracts, controversies, agreements, promises, damages, judgments, executions, claims and demands, in law or equity, known or unknown, which, against the Peach Releasors, the Company Parties have, had or may have from the beginning of time through the Effective Date of this Agreement, arising out of or related to, directly or indirectly, the Merger and/or the Merger Agreement; including, but not limited to, claims arising under all federal, state and local statutes, laws and ordinances prohibiting, without limitation, breach of contract, breach of the covenant of good faith and fair dealing, breach of fiduciary duty, defamation or fraud and any alleged entitlement to costs fees, or expenses, including attorneys’ fees’; provided however, that the foregoing release shall exclude any claims for breach of obligations under this Agreement.

 

10.     Covenant Not to Sue .

 

Except to enforce any obligation or right set forth in this Agreement or the attachments hereto, each of the Parties covenants and agrees that he, she or it will not hereafter commence, maintain or prosecute any action or proceeding at law or otherwise, assert any right of any nature, or assert any claim against for damages or loss of any kind or amount or for any other legal or equitable relief that he, she or it may have or claim to have at this time or at any time heretofore against the other Party relating to the claims released by the Parties herein.

 

11.     No Assignment of Claims; No Actions Pending.

 

The Parties, and each of them, represent and warrant that they are the sole and lawful owners of all rights, titles and interest in and to every claim and other matters which they release or confer herein, and that no other person, individual, or entity has received any assignment or other right of substitution or subrogation to any matters relating to or arising out of the Merger Agreement and any transaction related thereto. Each Party represents, warrants, and agrees that no legal proceeding or other action, including an arbitration proceeding, has been filed in any forum arising out of, from, or in connection with any disputes or claims arising out of or related to the claims released in this Agreement.

  

6

 

 

12.     Confidentiality.

 

The Parties shall not directly or indirectly disclose or make any statement (written or oral) to any person, firm or entity not a party to this Agreement with respect to the matters covered by this Agreement, execution of this document, the settlement, the terms and conditions of the settlement, disclosures and representations made in this document, or anything else in connection with this matter, except for any disclosure required to comply with any governmental rule, law, statute, regulatory or reporting requirement (including in response to any inquiry by, or requirement of the Securities and Exchange Commission and the disclosure obligations pursuant to the rules and regulations promulgated thereby), arbitration or court proceeding, and except for any disclosure to the Parties’ accountants and attorneys for personal tax and business purposes. Any Party receiving a subpoena or order, which seeks to compel disclosure of this Agreement, shall afford the other Party five (5) days’ notice to quash or limit such subpoena or order. In the event of any breach of the confidentiality terms of this Agreement, the aggrieved party’s remedies shall be limited to injunctive relief only.

 

13.     No Admission of Liability.

 

The Parties acknowledge and agree that this Agreement is being executed in order to resolve and forever set at rest all the controversies of whatever nature that may exist between the Parties, and that neither the Agreement or general releases set forth herein nor the underlying settlement constitute or are to be construed as an acknowledgment or admission of any liability whatsoever, any such liability being expressly denied.

 

14.     Representations and Warranties of the Former Memb ers .   Each of the Former Members represents and warrants to the Company and Peachstate, each for himself or herself and not the other, as of the date hereof that:

 

a.      Authorization .    The execution, delivery and performance by such Former Member of this Agreement and the consummation of the transactions contemplated hereby, including the release of claims herewith, has been duly authorized by all necessary action and this Agreement constitutes a valid and binding agreement of such Former Member, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights and remedies generally.

 

b.      Non-Contravention .    The execution and delivery by such Former Member of this Agreement, the consummation of the transactions contemplated hereby and thereby, and compliance by such Former Member with any of the provisions hereof and thereof will not conflict with, constitute a default under or violate any of the terms, conditions or provisions of (x) any document, agreement or other instrument to which such Former Member is a party or by which their property is bound, or (y) any judgment, writ, injunction, decree, order or ruling of any court or governmental authority binding on such Former Member or their property.

 

c.      Accredited Investor Status . Each Former Member is an “accredited investor” as defined in Rule 501(a) under the Securities Act. Such Former Member is not a registered person under Section 15 of the Exchange Act. Such Former Member has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of acquiring the shares of the Company’s Common Stock hereunder, and has so evaluated the merits and risks of such investment. Such Former Member is able to bear the economic risk of this transaction and, at the present time, is able to afford a complete loss of such investment.

 

7

 

 

d.      Information .   Such Former Member has reviewed all reports filed by the Company under the Securities Exchange Act of 1934, as amended, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof and has had and continues to have access to such information concerning the Company as it considers necessary to make an informed decision concerning consummating the transactions contemplated by this Agreement. Such Former Member acknowledges that it has had the opportunity to ask questions of, and receive answers from, the officers of the Company concerning the operation and business of the Company.

 

e.      Restricted Shares. Such Former Member understands and agrees that the shares of the Company’s Common Stock issuable under this Agreement are restricted shares under the Securities Act and may not be sold except pursuant to an effective registration statement or an exemption from the registration requirements of the Securities Act and applicable state securities laws, and will bear a restrictive legend as required under the Securities Act, in substantially the following form:

 

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN AGREEMENT DATED JULY 19, 2018.

 

 Each Former Member understands that the shares of Common Stock issuable hereunder may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of any such shares other than pursuant to an effective registration statement or Rule 144, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred shares under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement.

 

f.      Acquisition for O wn Account. Each Former Member further acknowledges that he or she is acquiring the shares of the Company’s Common Stock for his or her own account and not with a view to or for distributing or reselling such shares of Common Stock or any part thereof in violation of any applicable federal or state securities law, has no present intention of distributing any of such shares of Common Stock in violation of the securities laws and has no direct or indirect arrangement or understandings with any other persons to distribute the shares of Common Stock in violation of any applicable securities law (this representation and warranty not limiting the Former Member’s right to sell the shares of Common Stock or any part thereof in compliance with applicable federal and state securities laws or as otherwise provided in this Agreement.

 

g.      Limited Trading Market . Each Former Member understands and acknowledges that there is a limited trading market for the Company’s Common Stock and public sales of significant amounts of the Company’s Common Stock may have a material adverse effect on the price of the Company’s Common Stock.

 

8

 

 

h.      Reliance on Representations . Each Former Member understands that the shares of Common Stock issuable hereunder are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Former Member’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of it set forth herein in order to determine the availability of such exemptions and the eligibility of such Former Member to acquire the shares.

 

i.      No General Solicitation . Such Former Member acknowledges that the shares of Common Stock issuable hereunder were not offered to the it by means of any form of general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including: (i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast over television or radio; or (ii) any seminar or meeting to which the such Former Member was invited by any of the foregoing means of communications.

 

j.      No Legal, Tax or Investment Advice .   Such Former Member understands that the tax consequences of the transactions contemplated by this Agreement are complex, and accordingly such Former Member represents and warrants that it understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to him, her or it in connection with this Agreement and the transactions contemplated herein, constitutes legal, tax or investment advice.  Such Former Member has consulted such legal, tax and investment advisors as he, she or it, in his, her or its sole discretion, has deemed necessary or appropriate in the circumstances.  Such Former Member is not relying on the Company or any of its respective affiliates or agents, including its counsel and accountants, for any tax advice regarding the tax consequences of the transactions contemplated by this Agreement.

 

15.      Representations and Warranties of the Company.    The Company represents and warrants to each Former Member as of the date hereof that:

 

a.      Due Incorporation . The Company has been duly incorporated and is validly existing and in good standing under the laws of the state of Delaware, with full corporate power and authority to own, lease and operate its properties and to conduct its business as currently conducted. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document; (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole; or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a Material Adverse Effect ) and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

b.      Authorization .  The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby, including the release of claims, have been duly authorized by all necessary action on the part of the Company. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

9

 

 

c.      Issuance of the Company Shares .   The shares of Common Stock issuable pursuant to this Agreement have been duly authorized by all necessary corporate action and, when issued in accordance with the terms of this Agreement shall have been validly issued, fully paid and nonassessable. The Company will deliver to Former Members good and valid title to such shares of Common Stock free and clear of any lien, security interest or other encumbrance.

 

d.      Non-Contravention .    The execution and delivery by the Company of this Agreement, the consummation of the transactions contemplated hereby, and compliance by the Company with any of the provisions hereof will not conflict with, constitute a default under or violate (x) any of the terms, conditions or provisions of its certificate of incorporation or by-laws, (y) any of the terms, conditions or provisions of any document, agreement or other instrument to which it is a party or by which its property is bound, or (z) any judgment, writ, injunction, decree, order or ruling of any court or governmental authority binding on the Company or its property.

 

16.     No Reliance on Representations.

 

The Parties acknowledge that in entering into this Agreement they have not relied upon any representations, warranties, promises or conditions made by each of the Parties or each of the Parties’ agents or representatives not specifically set forth in this Agreement. The Parties acknowledge that each of them has freely executed this Agreement after independent investigation, with the advice of independent counsel and without fraud, duress or undue influence, and that each understands its content. Each Party is aware that it or its attorneys may hereafter discover facts different from or in addition to the facts that it now knows or believes to be true with respect to the subject matter of this Agreement or the other Party hereto, but that it is its intention to fully and finally release each of its respective releasees to the full extent of the releases contained in this Agreement, and to otherwise agree to the other terms and conditions of this Agreement.

 

17.     Further Assurances.

 

From time to time after the date hereof, the Parties shall take such other actions and execute and deliver to any other Party such further documents as may be reasonably requested by any other Party in order to assure and confirm unto such Party (a) the rights created hereby or intended now or hereafter so to be created by this Agreement; or (b) the validity of any assignment documents or other documents of conveyance to be delivered at the execution of this Agreement. The Company shall at all times, in performing under this Agreement, comply with all applicable federal and state securities laws.

 

10

 

 

18.     Construction and Independent Representation .

 

The language of this Agreement shall be construed as a whole, according to its fair meaning, and not strictly for or against either of the Parties. For purposes of construction, this Agreement shall be deemed to have been drafted by all the Parties, and no ambiguity shall be resolved against any Party by virtue of his or her participation in the drafting of this Agreement. Section headings have been inserted for convenience of reference only and are not intended to be a part of, or to affect, the meaning or interpretation of this Agreement. In the event that this Agreement is construed, it shall be construed to effectuate the intention of the Parties. Each Party (other than the Company) expressly represents and warrants to the Company that (a) before executing this Agreement, it has fully informed himself, herself or itself of the terms, contents, conditions and effects of this Agreement; (b) said Person has relied solely and completely upon his, her or its own judgment in executing this Agreement; (c) said Person has had the opportunity to seek the advice of his, her or its own counsel and advisors before executing this Agreement; (d) said Person has acted voluntarily and of his, her or its own free will in executing this Agreement; (e) this Agreement is the result of arm’s length negotiations conducted by and among the Parties; and (f) said Person acknowledges that the law firm of Becker & Poliakoff, LLP has been retained by the Company to prepare this Agreement as legal counsel for the Company, that Becker & Poliakoff, LLP does not represent any other Party in connection with the preparation or execution of this Agreement, that such firm has not given any legal, investment or tax advice to any other Party regarding this Agreement, and that such other Party has not relied upon any legal advice except as provided by its own attorneys. Becker & Poliakoff, LLP is expressly intended as a beneficiary of the representations and warranties of the Holders contained in this Section.

 

19.     Notices.

 

All notices or other communications which are required or permitted hereunder shall be in writing and sufficient if delivered by hand, by facsimile transmission, by registered or certified mail, postage pre-paid, or by courier or overnight carrier, to the persons at the addresses set forth below (or at such other address as may be provided hereunder):

 

If to Peachstate :

 

PeachState Health Management LLC, d/b/a AEON Clinical Laboratories

2225 Centennial Drive

Gainesville, GA 30504

Attn: Sonny Roshan, Chief Executive Officer

Fax: 678.971.4830

 

If to a Former Member :

 

To the address of such Former Member as is set forth on the books and records of the Company.

 

If to the Company :

 

Aeon Global Health Corp.

2225 Centennial Drive

Gainesville, GA 30504

Attn: Michael Poelking, Chief Financial Officer

Fax: 678.971.4830

 

With a copy to (which shall not constitute notice):

 

Becker & Poliakoff LLP

45 Broadway, 17 th  Floor

New York, NY 10006

Attn: Victor DiGioia, Esq.

Fax: 212-557-0295

 

11

 

 

or to such other address as the party to whom notice is to be given may have furnished to the other party in writing in accordance herewith. All such notices or communications shall be deemed to be received (i) in the case of personal delivery, on the date of such delivery; (ii) in the case of nationally-recognized overnight courier, on the next Business Day after the date when sent; (iii) in the case of facsimile transmission or telecopier or electronic mail, upon confirmed receipt; and (iv) in the case of mailing, on the third Business Day following the date on which the piece of mail containing such communication was posted.

 

20.     Miscellaneous.

 

2 1 . 1       Effect of Agreement. Upon the Effective Date, (i) the applicable portions of this Agreement shall amend the Merger Agreement, and (ii) each reference in any document to “this Agreement”, “hereof”, “hereunder”, or words of like import, and each reference in any other document or agreement to the Merger Agreement shall mean and be a reference to the Merger Agreement as amended hereby.

 

21.2      Entire Agreement.     This Agreement and the documents, instruments and exhibits referred to herein constitute the entire agreement between the Parties with respect to the transactions contemplated hereunder and supersede all prior arrangements or understandings with respect thereto, written or oral. Nothing in this Agreement expressed or implied, is intended to confer upon any Person, other than the Parties or their respective successors, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

2 1 . 3       Amendments. To the extent permitted by law, this Agreement may be amended by a subsequent writing signed by each of the Parties upon the approval of each of the Parties, whether before or after stockholder approval of this Agreement has been obtained.

 

2 1 . 4       Waivers. No provision of this Agreement may be waived in whole or in part, except by a written agreement signed by all of the Parties hereto. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. The failure of any Party at any time or times to require performance of any provision hereof shall in no manner affect the right of such Party at a later time to enforce the same or any other provision of this Agreement.

 

2 1 . 5       Assignment. Except as expressly contemplated hereby, neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any Party hereto (whether by operation of law or otherwise) without the prior written consent of the other Parties. Subject to the preceding sentence, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns.

 

21 . 6       Governing Law.    Regardless of any conflict of law or choice of law principles that might otherwise apply, the Parties agree that this Agreement shall be governed by and construed in all respects in accordance with the laws of the State of Delaware. The Parties all expressly agree and acknowledge that the State of Delaware has a reasonable relationship to the Parties and/or this Agreement. As to any dispute, claim, or litigation arising out of or relating in any way to this Agreement or the transaction at issue in this Agreement, the Parties hereto hereby agree and consent to be subject to the exclusive jurisdiction of any Delaware state court, or federal court of the United States of America sitting in Delaware, and any appellate court from any thereof. Each Party hereto hereby irrevocably waives, to the fullest extent permitted by law: (a) any objection that it may now or hereafter have to laying venue of any suit, action or proceeding brought in such court; (b) any claim that any suit, action or proceeding brought in such court has been brought in an inconvenient forum; and (c) any defense that it may now or hereafter have based on lack of personal jurisdiction in such forum.

 

12

 

 

2 1 . 7       Counterparts.    This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

2 1 . 8      Captions. The captions contained in this Agreement are for reference purposes only and are not part of this Agreement. Unless otherwise indicated, all references to particular sections shall mean and refer to the referenced sections of this Agreement.

 

2 1 . 9       Enforcement of Agreement. The Parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement was not performed in accordance with its specific terms or was otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity.

 

2 1 . 10       Survival and Severability. The representations and warranties contained in this Agreement shall be continuing and shall survive the execution and delivery of this Agreement. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as is enforceable.

 

21.1 1       Fees and Expenses . Except as expressly set forth in this Agreement to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.

 

THE PARTIES HAVE READ THE FOREGOING AGREEMENT , UNDERSTAND THE MEANING OF SAME, AND FREELY, KNOWINGLY AND WITH THE ADVICE OF COUNSEL, AFTER DUE CONSIDERATION, VOLUNTARILY ENTER INTO THIS AGREEMENT.

 

 

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

13

 

 

IN WITNESS WHEREOF , the Parties have signed, or have caused this Agreement to be executed by their respective duly authorized representatives, as of the date first set forth above

 

 

AEON GLOBAL HEALTH CORP.

 

 

By:     /s/ Michael J. Poelking

Name: Michael J. Poelking      

Title: Chief Financial Officer

 

 

PEACHSTATE HEALTH MANAGEMENT LLC

 

 

By: /s/ Michael J. Poelking

Name: Michael J. Poelking      

Title: Chief Financial Officer

 

THE FORMER MEMBERS:

 

Hanif A. Roshan

 

 

By:   /s/ Hanif A. Roshan                        

Percentage Interest: 36.46%

 

Holly Carpenter

 

 

By:  /s/ Holly Carpenter

Percentage Interest: 10.42%

     

Gulzar Roy

 

 

By:  /s/ Gulzar Roy

Percentage Interest: 20.83%

 

Shawn Desai

 

 

By:  /s/ Shawn Desai

Percentage Interest: 10.42%

     

Sohail Ali

 

 

By:  /s/ Sohail Ali

Percentage Interest: 20.83%

 

Lissa H. Suda

 

 

By:  /s/ Lissa H. Suda

Percentage Interest: 1.04%

 

 

 

 

 

Signature Page to  Settlement and Restructuring Agreement

 

14

  Exhibit 10.2

 

 

NOTE EXCHANGE AGREEMENT

 

THIS NOTE EXCHANGE AGREEMENT (this “ Agreement ”) is dated as of July 19, 2018, between Aeon Global Health Corp., a Delaware corporation (the “ Company ”) and the holders identified on the signature pages hereto (each, a “ Holder ” and collectively, the “ Holder s ”).

 

  Recitals

 

WHEREAS, pursuant to the terms and conditions of this Agreement, the Company hereby offers to the Holders the New Notes (as defined below), and the Holders wish to purchase and acquire such New Notes in exchange for the surrender and cancellation of one or more promissory notes presently held by the Holders, the terms and conditions of which are set forth on the signature page to this Agreement (the “ O riginal Note s ”) upon the terms and conditions set forth herein; and

 

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby agreed and acknowledged, the parties hereto hereby agree as follows:

 

1.       Defined Terms . In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the New Note or Security Agreement (as defined herein); and (b) the following terms have the meanings set forth in this Section 1:

 

Affiliate ” of any specified Person means any other Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person.  For the purposes of this definition, “control”, when used with respect to any specified Person, means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

 

Business Day ” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

Closing Date ” means the Business Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to: (i) the Holders’ obligations to surrender the Original Note and (ii) the Company’s obligations to deliver the New Note have been satisfied or waived.

 

Commission ” means the United States Securities and Exchange Commission.

 

Common Stock ” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

Consent Agreement ” means that certain agreement entered into by certain of the Senior Holders consenting to the issuance of the New Notes on the terms contemplated hereby.

 

E ncumbrances ” shall mean any security or other property interest or right, claim, lien, pledge, option, charge, security interest, contingent or conditional sale, or other title claim or retention agreement interest or other right or claim of third parties, whether perfected or not perfected, voluntarily incurred or arising by operation of law, and including any agreement (other than this Agreement) to grant or submit to any of the foregoing in the future.

 

Exchange Act ” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

1

 

 

New Note (s) ” means the senior secured grid notes due, subject to the terms therein, on June 30, 2020, as issued by the Company to the Holders hereunder, in the maximum principal amount as stated on the face of the instrument evidencing such loan and pursuant to which an amount of principal shall be deemed outstanding on the date of issuance equal to the sum of (i) the principal amount of the Original Note(s) held by such Holders, plus (ii) the accrued and unpaid interest thereon, up to the Business Day immediately preceding the Closing Date, which New Notes shall be in the form of Exhibit A attached hereto.

 

Person ” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

Required Approvals ” shall have the meaning ascribed to such term in Section 4(d).

 

Securities Act ” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

Security Agreement Amendment ” means an amendment to that certain Amended and Restated Security Agreement dated as of March 20, 2017, as amended prior to the date hereof (the “ Security Agreement ”), which provides for the inclusion of the New Notes as a secured note under the terms of such Amended and Restated Security Agreement.

 

Prior S enior Note s ” means those certain senior secured convertible notes, in the aggregate principal amount of $3,049,651, of which the aggregate principal amount of $2,545,199 was originally issued by the Company on March 20, 2017 and the aggregate principal amount of $504,452 was originally issued by the Company on March 27, 2018, in each case as such senior notes have been amended to date.

 

Senior Holders ” means the holders of the Prior Senior Notes.

 

Transaction Documents ” means this Agreement, the New Notes, the Security Agreement Amendment, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

2.            Securities Exchange .

 

2.1         Exchange and Closing

 

(a)    Upon the following terms and subject to the conditions contained herein, each Holder agrees to exchange from the Company the Original Note(s) and each Holder shall deliver and surrender to the Company at its principal offices for cancellation such Original Note(s) held by Holder, free and clear of any liens, claims, charges, security interest or other legal or equitable Encumbrances in exchange for a New Note with a maximum principal amount as set forth on such Holder’s signature page to this Agreement. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the closing of the transactions contemplated by this Agreement (the “ Closing ”) shall occur at the offices of Company’s counsel or such other location and on such Business Day as the parties shall mutually agree.

 

(b)    At Closing, the New Notes issued in exchange for cancellation of the Original Notes shall be deemed the full and final consideration for the cancellation of such Original Notes, and notwithstanding anything to the contrary contained in the Original Notes or otherwise, the Company and Holders hereby agree that upon the Closing: (i) the Company’s obligations under the Original Notes held by Holder shall be deemed fully paid and satisfied; and (ii) the Original Notes shall automatically terminate and have no further force and effect (other than those specific provisions which pursuant to the terms and provisions of the Original Notes which expressly survive termination). Further, the Company and Holders hereby agree that upon the Closing the Company’s obligations to Holders pursuant to any security agreements previously entered into between the Company and Holder shall be modified to include the terms and conditions of the Security Agreement Amendment entered into between the Company and the Holders pursuant to this Agreement.

 

2

 

 

(c)      Each Holder further agrees that it will write “PAID IN FULL” on the original of the Original Notes surrendered to the Company pursuant to this Agreement and initial such phrase and return the originally executed version of the Original Notes to the Company. Notwithstanding the foregoing, however, in the event the Holder does not inscribed the phrase “PAID IN FULL” on the Original Notes, it hereby authorizes the Company’s agents and officers to write such phrase on the Original Notes. In the event Holder has lost his, her or its Original Notes, or such Original Notes were lost, stolen or destroyed, Holder shall, instead of returning the Original Notes, execute and deliver to the Company an affidavit of loss and indemnification undertaking (in a form acceptable to the Company) with respect to such Original Notes and in which instrument the Holder acknowledges that the Original Notes are cancelled and paid in full.

 

2.2        Deliveries .

 

(a)      On or prior to the Closing Date (except as otherwise provided below), the Company shall deliver or cause to be delivered to each Holder the following: (i) this Agreement duly executed by the Company; (ii) the Security Agreement Amendment, duly executed by the Company; (iii) a New Note registered in the name of each Holder (such original New Note may be delivered within three Business Days following Closing Date); (iv) an agreement executed by the landlord of the premises in which the Company’s principal place of business is located pursuant to which the landlord agrees to subordinate its security interest into certain assets of the Company to the security interests to be granted to the Holder pursuant to the Security Agreement Amendment; and (v) such other documents relating to the transactions contemplated by this Agreement as the Holder or its counsel may reasonably request.

 

(b)      On or prior to the Closing Date, each Holder shall deliver or cause to be delivered to the Company, as applicable, the following: (i) this Agreement duly executed by such Holder; (ii) the Security Agreement Amendment, duly executed by such Holder; (iii) the Holder’s Original Note(s) (or an affidavit of loss and indemnity undertaking with respect thereto, in a form reasonably acceptable to the Company); and (iv) such other documents relating to the transactions contemplated by this Agreement as the Company or its counsel may reasonably request.

 

2.3        Closing Conditions .

 

(a)      The obligations of the Company hereunder in connection with the Closing are subject to the satisfaction, or waiver by the Company, of the following conditions: (i) the accuracy in all material respects on the Closing Date of the representations and warranties of the Holders contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); (ii) all obligations, covenants and agreements of the Holders required to be performed at or prior to the Closing Date shall have been performed; (iii) the delivery by the Holders of the items set forth in Section 2.2(b) of this Agreement; (iv) that certain Settlement and Restructuring Agreement by and among the Company, Peachstate Health Management LLC d/b/a AEON Clinical Laboratories (“Peachstate”), and the former members of Peachstate included on the signature page thereto (the “Settlement Agreement”) have executed the Settlement Agreement and delivered it to the Company; and (v) the Company shall have received any Required Approvals necessary to conduct the Closing.

 

(b)      The obligations of each Holder hereunder in connection with the Closing are subject to the satisfaction, or waiver by such Holder, of the following conditions: (i) the accuracy in all material respects when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein); (ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed; (iii) the Settlement Agreement by and among the Company, Peachstate, and the former members of Peachstate included on the signature page thereto have executed the Settlement Agreement and delivered it to the Company; and (iv) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement.

 

3

 

 

3.         Representations, Warranties and Covenants of  Holder s .  Each Holder hereby makes the following representations and warranties to the Company, and covenants for the benefit of the Company.

 

(a)     Due Organization and Authorization; Binding Agreement . If Holder is an entity, such Holder is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization. Holder has full right, power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby. This Agreement has been duly and validly authorized, executed and delivered by Holder and (assuming due authorization, execution and delivery by the Company) constitutes the valid and binding obligation of Holder enforceable against Holder in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, and general equitable principles (whether considered in a proceeding in equity or at law).

 

(b)     No Conflicts . The execution, delivery and performance of this Agreement by the Holder and the consummation by the Holder of the transactions contemplated hereby do not and will not: (i) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Holder is a party or by which the Holder’s properties or assets are bound; or (ii) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Holder or by which any property or asset of the Holder are bound or affected, except, in each case, for such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, materially and adversely affect the Holder’s ability to perform its obligations under this Agreement. No consent, approval, authorization or order of any person, entity, court, administrative agency or governmental authority is required for the execution, delivery or performance of this Agreement by the Holder.

 

(c)     Holder Status . At the time such Holder was offered the New Note, it was, and as of the date hereof it is either: (i) an “accredited investor” as defined in Rule 501(a) under the Securities Act; or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Each Holder is not required to be registered as a broker-dealer under Section 15 of the Exchange Act. Each Holder has sufficient knowledge and experience in financial matters as to be capable of evaluating the risks and merits of the transaction contemplated hereby. Each Holder is able to bear the economic risk of its investment in the New Notes for an indefinite period of time, is able to afford a complete loss of such investment, and acknowledges that no public market exists for the New Notes and that there is no assurance that a public market will ever develop for such securities. The New Notes have not been registered under the Securities Act and, therefore, cannot be sold unless subsequently registered under the Securities Act or an exemption from such registration is available.

 

(d)      Information . Each Holder has reviewed, or has had the opportunity to review, with the assistance of professional and legal advisors of its choosing, all information (including all documents filed or furnished to the Commission by the Company) relating to the business, finances and operations of the Company and materials relating to the exchange transaction which have been requested by such Holder. Such Holder has been afforded the opportunity to ask questions of the Company and has had sufficient access to the Company necessary for such Holder to decide to exchange its Original Notes for the New Notes in accordance with this Agreement. Such Holder acknowledges that all of the documents filed by the Company with the Commission under Sections 13(a), 14(a) or 15(d) of the Exchange Act, that have been posted on the EDGAR site maintained by the Commission are available to such Holder, and such Holder has not relied on any statement of the Company not contained in such documents in connection with such Holder’s decision to enter into this Agreement or any other Transaction Document and to consummate the transactions contemplated hereby.

 

(e)      Certain Disqualification Events . Neither the Holder, nor any director, executive officer, other member or officer of the Holder participating in the transactions contemplated by this Agreement, any beneficial owner of 20% of more of the Holder’s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Holder in any capacity at the time of sale (each a Holder Covered Person ”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a Disqualification Event ), except for a Disqualification Event covered by Rule 506(d)(2) or (3) (provided that the foregoing exception shall not be available hereunder with respect to Rule 506(d)(2)(iv) for any Disqualification Event of which the Company did not know as a result of the Holder’s failure to disclose such Disqualification Event to the Company). Holder has exercised reasonable care to determine: (i) the identity of each person that is a Holder Covered Person; and (ii) whether any Holder Covered Person is subject to a Disqualification Event.

 

4

 

 

(f)      Own Account . Each Holder is and will be acquiring the New Notes for such Holder’s own account, for investment purposes, and not with a view to any resale or distribution in whole or in part, in violation of the Securities Act or any applicable securities laws; provided , however , that by making the representations herein, such Holder does not agree to hold such New Notes for any minimum or other specific term and reserves the right to dispose of the New Notes at any time in accordance with federal and state securities laws applicable to such disposition.

 

(g)      Restricted Securities . Each Holder understands that the New Notes purchased hereunder are “restricted securities,” as that term is defined in the Securities Act and the rules thereunder, have not been registered under the Securities Act, and that such New Notes cannot be sold or transferred unless they are first registered under the Securities Act and such state and other securities laws as may be applicable or an exemption from registration under the Securities Act is available (and then may be sold or transferred only in compliance with such exemption and all applicable state and other securities laws). Holder acknowledges that all certificates representing any of the New Notes will bear a restrictive legend in a form as set forth below. Holder further understands that except as provided in the Transaction Documents: (i) the New Notes have not been and are not being registered under the Securities Act or any state securities laws, must be held indefinitely and may not be offered for sale, sold, assigned or transferred unless permitted in accordance with the terms of such New Notes or the other Transaction Documents and: (A) subsequently registered thereunder; (B) Holder shall have delivered to the Company an opinion of counsel, in a generally acceptable form, to the effect that such New Notes to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration; or (C) Holder provides the Company with reasonable assurance that such New Notes can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A promulgated under the Securities Act (or a successor rule thereto) (collectively, Rule 144 ); (ii) any sale of the New Notes made in reliance on Rule 144 may be made only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the New Notes under circumstances in which the seller (or the Person (through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require compliance with some other exemption under the Securities Act or the rules and regulations of the Commission thereunder; and (iii) except as set forth in the Transaction Documents, neither the Company nor any other Person is under any obligation to register the New Notes under the Securities Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder.

 

(h)      Reliance on Representations . Each Holder understands that the New Notes are being offered and sold to it in reliance on specific exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and Holder’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of Holder set forth herein in order to determine the availability of such exemptions and the eligibility of Holder to acquire the New Notes. The Holder undertakes to immediately notify the Company of any change in any statement or other information relating to the Holder which takes place prior to the Closing time. No Person has made any written or oral representations to the Holder that: (i) any Person will resell or repurchase the New Note or (ii) as to the future price or value of the shares of Common Stock of the Company.

 

(i)       No Brokers . The Holder has not employed any broker or finder or incurred any liability for any brokerage or investment banking fees, commissions, finders’ structuring fees, financial advisory fees or other similar fees in connection with any of the transactions contemplated by this Agreement.

 

(j)       No General Solicitation . Each Holder acknowledges that the New Notes were not offered to such Holder by means of any form of general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including: (i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast over television or radio; or (ii) any seminar or meeting to which such Holder was invited by any of the foregoing means of communications.

 

5

 

 

(k)      Representations Regarding Original Note s . Each Holder owns and holds, beneficially and of record, the entire right, title, and interest in and to the Original Note(s) held by it, free and clear of any and all pledges, liens, security interests, mortgage, claims, charges, restrictions, options, title defects or Encumbrances other than restrictions under the Securities Act and other applicable federal and state securities laws. Holder has not, in whole or in part, (x) assigned, transferred, hypothecated, pledged or otherwise disposed of the Original Note(s) or its rights in such Original Note(s), or (y) given any person or entity any transfer order, power of attorney or other authority of any nature whatsoever with respect to such Original Note(s) which would limit the Holder’s power to transfer the Original Note(s) hereunder. Holder has the sole and unencumbered right and power to transfer and dispose of the Original Note(s), and such Original Note(s) are not subject to any agreement, arrangement or restriction with respect to the transfer of the Original Note(s), except for this Agreement. No additional consideration for any purpose shall be due to Holder at Closing, with respect to the Original Note(s), other than the New Note. Upon delivery of the Original Note(s) to the Company for cancellation (as contemplated by this Agreement), the Company will receive good and marketable title to the Original Note(s), free and clear of all pledges, liens, security interests, mortgage, claims, charges, restrictions, options, title defects or Encumbrances. The Original Note(s) being surrendered by it for cancellation pursuant to this Agreement represent all of the Original Note(s) of the Company in which Holder owns any legal or beneficial interest. No Event of Default (as defined in the Original Note(s) has been declared under the Original Note(s) and no Event of Default exists or is continuing with respect to the Original Note(s).

 

(l)       No Representations . No person or entity, other than the Company, has been authorized to give any information or to make any representation on behalf of the Company in connection with the offering of the New Notes, and if given or made, such information or representations have not been relied upon by the Holder as having been made or authorized by the Company.  The only representations and warranties made by the Company in connection with the transactions contemplated by this Agreement are those contained in this Agreement, and the only information made available by the Company in connection therewith is contained in this Agreement.

 

(m)      No Legal, Tax or Investment Advice .  Each Holder understands that the tax consequences of the transactions contemplated by this Agreement are complex, and accordingly such Holder represents and warrants that it understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to him, her or it in connection with this Agreement and the transactions contemplated herein, constitutes legal, tax or investment advice. Such Holder has consulted such legal, tax and investment advisors as he, she or it, in his, her or its sole discretion, has deemed necessary or appropriate in the circumstances. Such Holder is not relying on the Company or any of its respective affiliates or agents, including its counsel and accountants, for any tax advice regarding the tax consequences of the transactions contemplated by this Agreement.

 

(n)      No Governmental Review . Such Holder understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or endorsement in connection with the transactions contemplated by this Agreement or the fairness or suitability of the investment in the New Note nor have such authorities passed upon or endorsed the merits of the New Note.

 

4.       Representations, Warranties and Covenants of the Company .  The Company represents and warrants to the Holders, and covenants for the benefit of the Holders, as follows:

 

(a)      Due Organization . The Company has been duly incorporated and is validly existing and in good standing under the laws of the state of Delaware, with full corporate power and authority to own, lease and operate its properties and to conduct its business as currently conducted. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document; (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole; or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a Material Adverse Effect ) and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

6

 

 

(b)       Due Authorization; Binding Agreement; No Conflicts . The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to the Required Approvals and except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies; and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(c)       Validity of New Note . The New Note issued pursuant to this Agreement, when delivered in exchange for the Original Note(s) in accordance with this Agreement, will be the valid and binding obligations of the Company enforceable against the Company in accordance with their terms, subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting creditors’ rights generally, and general equitable principles (whether considered in a proceeding in equity or at law).

 

(d)      Filings, Consents and Approvals . The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) those that have previously been obtained; (ii) the filings required pursuant to the Exchange Act; and (iii) such other filings with the Commission as may be required under the Securities Act and such filings as are required to be made under applicable state securities laws (collectively, the Required Approvals ).

 

5.             Other Agreements .

 

5.1       Transfer Restrictions .

 

(a)      The New Notes may only be disposed of in compliance with their terms and with state and federal securities laws. In connection with any permissible transfer of New Notes other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Holder, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred New Notes under the Securities Act. As a condition of any permitted transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights and obligations of a Holder under this Agreement.

 

(b)      The Holders agree to the imprinting, so long as is required by this Section 5.1, of a legend on the New Notes substantially in the following form:

 

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE FEDERAL OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR HYPOTHECATED IN ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH LAWS AS MAY BE APPLICABLE OR, AN OPINION OF COUNSEL THAT AN EXEMPTION FROM SUCH APPLICABLE LAWS EXIST.

 

5.2       Waiver of Interest .  The Holder hereby irrevocably waives any and all claims, demands, suits, actions, causes of action and rights whatsoever at law or in equity, now existing or arising relating to any accrued and unpaid interest on the Original Note(s) or any other agreement between the parties.  The Holder hereby acknowledges and agrees that it shall not commence or prosecute in any way, or cause to be commenced or prosecuted, any action in any court relating to such accrued and unpaid interest.

 

7

 

 

6.         Miscellaneous .

 

6.1       Governing Law; Consent to Jurisdiction . This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts of laws principles thereof. Each party hereto agrees that it shall bring any action, proceeding, suit, demand, or claim with respect to any matter arising out of or related to this Agreement or the transactions contained in or contemplated by this Agreement, exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the State of Delaware (unless the Delaware Court of Chancery shall decline to accept jurisdiction over a particular matter, in which case, in any Delaware state or federal court within the State of Delaware) (such courts, collectively, the “ Delaware Courts ”), and solely in connection with claims arising under this Agreement or the transactions that are the subject of this Agreement (i) irrevocably submits to the exclusive jurisdiction of the Delaware Courts, (ii) waives any objection to laying venue in any such action or proceeding in the Delaware Courts, (iii) waives any objection that the Delaware Courts are an inconvenient forum or do not have jurisdiction over either party hereto, (iv) agrees that service of process upon such party in any such action or proceeding shall be effective if notice is given in accordance with Section 6.5 of this Agreement, although nothing contained in this Agreement shall affect the right to serve process in any other manner permitted by law and (v) agrees not to seek a transfer of venue on the basis that another forum is more convenient. Notwithstanding anything herein to the contrary, (A) nothing in this Section 6.1 shall prohibit any party from seeking or obtaining orders for conservatory or interim relief from any court of competent jurisdiction and (B) each party hereto agrees that any judgment issued by a Delaware Court may be recognized, recorded, registered or enforced in any jurisdiction in the world and waives any and all objections or defenses to the recognition, recording, registration or enforcement of such judgment in any such jurisdiction.

 

6.2      Confidentiality .  Each Holder acknowledges and agrees that the existence of this Agreement and the information contained herein and in the Exhibits hereto (collectively, “ Confidential Information ”) is of a confidential nature and shall not, without the prior written consent of the Company, be disclosed by the Holder to any person or entity, other than the Holder’s personal financial and legal advisors for the sole purpose of evaluating an investment in the Company, and that it shall not, without the prior written consent of the Company, directly or indirectly, make any statements, public announcements or release to trade publications or the press with respect to the subject matter of this Agreement.  Notwithstanding the foregoing, the Holder may use or disclose Confidential Information to the extent the Holder is required by law to disclose such Confidential Information, provided, however, that prior to any such required disclosure, Holder shall give the Company reasonable advance notice of any such disclosure and shall cooperate with the Company in protecting against any such disclosure and/or obtaining a protective order narrowing the scope of such disclosure and/or use of the Confidential Information.  The Holder further acknowledges and agrees that the information contained herein and in the other documents relating to this transaction may be regarded as material non-public information under United States federal securities laws, and that United States federal securities laws prohibit any person who has received material non-public information relating to the Company from purchasing or selling securities of the Company, or from communicating such information to any person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell securities of the Company.  Accordingly, until such time as any such non-public information has been adequately disseminated to the public, the Holder shall not purchase or sell any securities of the Company, or communicate such information to any other person.

 

6.3      Entire Agreement ; Amendment and Waivers .  This Agreement constitutes the entire understanding and agreement of the parties with respect to the subject matter hereof and supersedes all prior and/or contemporaneous oral or written proposals or agreements relating thereto all of which are merged herein.  This Agreement may not be amended or any provision hereof waived in whole or in part, except by a written amendment signed by all of the parties hereto. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.

 

6.4       Counterparts .  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page was an original thereof.

 

8

 

 

6.5      Notice s . Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Business Day; (b) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day; (c) the second (2 nd ) Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service; or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

6.6      Severability . Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction.

 

6.7      Survival . All representations and warranties made by the Company and each Holder will survive the execution of this Agreement and the Closing until the first anniversary of the Closing Date, except for those representations and warranties which speak as of a specific date. All covenants and other agreements set forth in this Agreement shall survive the Closing for the respective periods set forth therein and if no such period is specified until the first anniversary of the Closing Date.

 

6.8      Specific Performance; Enforcement . Each of the parties hereto recognizes and acknowledges that a breach by it of any covenants or agreements contained in this Agreement will cause the other party to sustain damages for which it would not have an adequate remedy at law for money damages, and therefore, each of the parties hereto agrees that in the event of any such breach the aggrieved party shall be entitled to the remedy of specific performance of such covenants and agreements and injunctive and other equitable relief in addition to any other remedy to which it may be entitled at law or in equity. The parties agree that they shall be entitled to enforce specifically the terms and provisions of this Agreement in addition to any other remedy to which they may entitled at law or in equity.

 

6.9      Assignment; Binding Effect; Benefits . This Agreement is not assignable without the written consent of each of the other parties hereto. Subject to the foregoing, the provisions of this Agreement shall be binding upon and inure to the benefit of the parties and their respective heirs, legal representatives, successors and permitted assigns. Except as expressly stated elsewhere herein, nothing in this Agreement, express or implied, is intended or shall be construed to give any person other than the parties or their respective successors or assigns any legal or equitable right, remedy or claim under or in respect of any agreement or any provision contained herein.

 

6.10      Independent Representation . Each Holder expressly represents and warrants to the Company that (a) before executing this Agreement, said Holder has fully informed himself or itself of the terms, contents, conditions and effects of this Agreement; (b) said Holder has relied solely and completely upon his or its own judgment in executing this Agreement; (c) said Holder has had the opportunity to seek the advice of his or its own counsel and advisors before executing this Agreement; (d) said Holder has acted voluntarily and of his or its own free will in executing this Agreement; (e) said Holder is not acting under duress, whether economic or physical, in executing this Agreement; (f) this Agreement is the result of arm’s length negotiations conducted by and among the parties; and (g) said Holder acknowledges that the law firm of Becker & Poliakoff, LLP has been retained by the Company to prepare this Agreement as legal counsel for the Company, that Becker & Poliakoff, LLP does not represent any Holder in connection with the preparation or execution of this Agreement, that such firm has not given any legal, investment or tax advice to any Holder regarding this Agreement, and that such Holder has not relied upon any legal advice except as provided by its own attorneys. Becker & Poliakoff, LLP is expressly intended as a beneficiary of the representations and warranties of the Holders contained in this Section 6.1 0 .     

 

9

 

 

6.11      Termination . If the Closing has not been consummated on or before July 31, 2018, this Agreement may be terminated (a) by any Holder (except where any such Holder is in breach of this Agreement or has failed to perform or satisfy any closing condition applicable to it), as to such Holder’s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Holders, or (b) by the Company (except for any breach by it or failure to perform or satisfy any closing condition applicable to it), by written notice to the other parties; provided , however , that such termination will not affect the right of any non-breaching party to sue or seek specific performance for any breach by any other party (or parties).

 

6.12      Construction . The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement. In this Agreement, unless the context otherwise requires: (i) words of the masculine or neuter gender will include the masculine, neuter and/or feminine gender, and words in the singular number or in the plural number will each include, as applicable, the singular number or the plural number, (ii) reference to any Person includes such Person’s successors and assigns but, if applicable, only if such successors and assigns are permitted by this Agreement, (iii) the words “include,” “includes” and “including” when used herein shall be deemed in each case to be followed by the words “without limitation,” (iv) reference to any law means such law as amended, modified codified or reenacted, in whole or in part, and in effect from time to time, including rules and regulations promulgated thereunder, (v) except as otherwise indicated, all references in this Agreement to the words “Section,” “Schedule” and “Exhibit” are intended to refer to Sections, Schedules and Exhibits to this Agreement, (vi) the headings of the Sections of this Agreement are for convenience only and in no way modify, interpret or construe the meaning of specific provisions of this Agreement, (vi) the words “herein,” “hereto,” and “hereby” and other words of similar import in this Agreement shall be deemed in each case to refer to this Agreement as a whole and not to any particular Section or other subdivision of this Agreement, (vii) any reference herein to “dollars” or “$” shall mean United States dollars, (viii) any reference herein to a Governmental Authority shall be deemed to include reference to any successor thereto, and (ix) the specificity of any representation or warranty contained herein shall not be deemed to limit the generality of any other representation or warranty contained herein.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 

10

 

 

[COMPANY SIGNATURE PAGE TO NOTE EXCHANGE AGREEMENT]

 

 

IN WITNESS WHEREOF , the Company and each Holder has caused this Agreement to be executed on its behalf as of the date first written above.

 

A EON GLOBAL HEALTH CORP.

       
   

Address for Notice :

2225 Centennial Drive

Gainesville, GA 30504

Attn: Chief Financial Officer

     

/s/ 

Michael J. Poelking

 

 

  Fax:

 
 

Name: Michael J. Poelking 

Title:  Chief Financial Officer

 

         
 

 

With a copy to (which shall not constitute notice):

 

           
 

Becker & Poliakoff, LLP

45 Broadway, 17 th Floor

New York, NY 10006

Attn: Michael A. Goldstein

Fax: 212-557-0295

           

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

11

 

 

[HOLDER SIGNATURE PAGE TO NOTE EXCHANGE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Note Exchange Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Holder:

 

Hanif A. Roshan

     

Signature of Authorized Signatory of Holder :

 

/s/ Hanif A. Roshan

     

Name of Authorized Signatory:

 

Hanif A. Roshan

     

Title of Authorized Signatory:

 

 

     

Email Address of Authorized Signatory:

 

sroshan@aeonglobalhealth.com

     

Facsimile Number of Authorized Signatory:

   
     

Social Security or Tax I.D. Number:

   
     

Address for Notices to Holder:

 

2225 Centennial Drive

   

Gainesville, GA 30504

     
     
     

Address for Delivery of certificated Securities for Holder (if not same as address for notices):

   
     
     
     

 

 

Maximum Principal Amount of New Note to be Issued at Closing: $ 1,100,000.00

 

Principal Amount Outstanding on New Note as of Issuance Date: $ 78 4 , 612 .00

 

Original Note (s) Owned by Holder and Issue Date (the “ Original Note ( s ) ”) :

 

1.

Promissory Note originally issued March 20, 2017 in the Principal Amount of $ 255,417.00 .

 

2.

Promissory Note originally issued Mach 27, 2018 in the Principal Amount of $ 504,452 .00 .

 

12

 

 

[HOLDER SIGNATURE PAGE TO NOTE EXCHANGE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Note Exchange Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

Name of Holder:

 

Optimum Ventures, LLC

     

Signature of Authorized Signatory of Holder :

   
     

Name of Authorized Signatory:

 

 /s/ Shawn Desai

     

Title of Authorized Signatory:

 

 Member

     

Email Address of Authorized Signatory:

 

 

     

Facsimile Number of Authorized Signatory:

   
     

Social Security or Tax I.D. Number:

   
     

Address for Notices to Holder:

 

2225 Centennial Drive

   

Gainesville, GA 30504

     
     
     

Address for Delivery of certificated Securities for Holder (if not same as address for notices):

   
     
     
     

 

 

Maximum Principal Amount of New Note to be Issued at Closing: $ 900,000.00

 

Principal Amount Outstanding on New Note as of Issuance Date: $ 630, 83 7 .00

 

Original Note (s) Owned by Holder and Issue Date (the “ Original Note ( s ) ”) :

 

1. Promissory Note originally issued March 20, 2017 in the Principal Amount of $ 591,613.00 .

 

13

 

 

EXHIBIT A

 

FORM OF N EW N OTE

 

 

14

  Exhibit 10.3

 

CONSENT A ND AMENDMENT A GREEMENT

 

This CONSENT AND AMENDMENT AGREEMENT (this “ Consent ”), dated as of July 19, 2018, is entered into by and among AEON GLOBAL HEALTH CORP., a Delaware corporation (the “ Company ”) and each of the holders of the Senior Notes (as such term is defined below) set forth on the signature pages hereto.

 

WHEREAS, the Company has issued an aggregate principal amount of $3,049,651 of Senior Secured Convertible Notes due March 20, 2019 (the “ S enior Notes ”);

 

WHEREAS, the Company’s obligations under the Senior Notes are secured by liens on substantially all of its assets pursuant to that certain Amended and Restated Security Agreement, dated as of March 20, 2017, between the Company and the holders of the Senior Notes, as amended on March 27, 2018 (collectively, the “ Security Agreement ”);

 

WHEREAS, the Company wishes to restructure an aggregate principal amount of $1,351,482 of Senior Notes held by Hanif A. Roshan and Optimum Ventures, LLC (the “ Exchanging Holders ”), pursuant to which the Exchanging Holders would agree to exchange their Senior Notes for new, secured non-convertible debt instruments pursuant to which such Exchanging Holders would make available a maximum of $2.0 million of debt capital to the Company (the “ New Credit Facility ”), which New Credit Facility would be issued on a parity basis with the Senior Notes;

 

WHEREAS, the Company and Exchanging Holders wish to obtain the consent of the other holders of the Senior Notes (such other holders being the “ Senior Holders ”) to the establishment of the New Credit Facility and the issuance of up to an aggregate principal amount of $2.0 million of new senior secured notes under the New Credit Facility, pursuant to which an aggregate principal amount of $1,415,449 would be deemed outstanding as of the date of issuance (the “ New Notes ”);

 

WHEREAS, the Company and Senior Holders desire to extend the maturity date of the Senior Notes held by them (the “ Convertible Senior Notes ”) and to amend certain other terms of the Convertible Senior Notes, as set forth herein; and

 

WHEREAS, the Company, Exchanging Holders and Senior Holders desire to amend and modify the Security Agreement to permit the establishment of the New Credit Facility and issuance of the New Notes on the terms set forth herein, and the undersigned Senior Holders have agreed to such amendments, modifications and other provisions set forth herein.

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

SECTION 1 .      Definitions . As used herein, terms that are defined herein shall have the meanings as so defined, and terms not so defined shall have the meanings as set forth in the Senior Notes and the Security Agreement, as applicable.

 

SECTION 2 .     Amendment s to the Security Agreement . In order to ensure that the liens granted to the holders of the New Notes are on parity with the liens granted to secure the obligations arising under the Senior Notes, the Senior Holders hereby agree and covenant to execute and deliver to the Company an amendment to the Security Agreement in the form annexed hereto as Exhibit A (the “ Amended Security Agreement ”).

 

 

 

 

SECTION 3.        Amendments to the Convertible Senior Notes . Effective immediately following the issuance of the New Notes to the Exchanging Holders (the “ Effective Time ”), each of the Convertible Senior Notes is hereby amended as follows:

 

(a)      The definition of the term “ Maturity Date ” of each Convertible Senior Note is hereby amended such that from and after the Effective Time, the term “ Maturity Date ” shall mean March 20, 2020.

 

(b)      The first sentence of Section 6(a) of each Convertible Senior Note is hereby amended and restated as follows:

 

“Subject to the provisions of this Section 6(a) and provided that the Company has filed all reports required to be filed by it pursuant to Sections 13(a), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “ SEC Reports ”), prior to the Optional Redemption Notice Date (defined below), then commencing 30 days following the date that the Company’s Common Stock is listed for trading on a National Securities Exchange and at any time thereafter, the Company may deliver a notice to the Holder (an “ Optional Redemption Notice ” and the date such notice is deemed delivered hereunder, the “ Optional Redemption Notice Date ”) of its irrevocable election to redeem some or all of the then outstanding principal amount of this Note for cash in an amount equal to the Optional Redemption Amount on the 90 th calendar day following the Optional Redemption Notice Date (such date, the “ Optional Redemption Date , ” such 90 day period, the “ Optional Redemption Period ” and such redemption, the “ Optional Redemption ”).”

 

SECTION 4 .          Acknowledgement and Consent .

 

(a)      Each of the Senior Holders executing this Consent hereby acknowledges and consents (i) to the establishment of the New Credit Facility and the issuance by the Company of the New Notes on the terms described herein; (ii) to the amendments to the Security Agreement and grant by the Company of the security interest in the Collateral (as defined in the Amended Security Agreement) to the holders of the New Notes; and (iii) to the modifications to the Convertible Senior Notes set forth herein. The Senior Holders further agree that the New Notes shall constitute “Permitted Indebtedness”, as defined in the Security Agreement, and that the liens granted to the holders of the New Notes under the Amended Security Agreement shall constitute “Permitted Liens”, as defined in the Security Agreement.

 

(b)     The Senior Holders further acknowledge and agree in all respects that (i) the New Notes shall, upon issuance, be pari passu with the Convertible Senior Notes with regard to priority of payment and in all other respects pertaining to their respective interests under the such instruments; and (ii) regardless of the relative times of attachment or perfection thereof, the security interests granted to the Senior Holders under the Security Agreement shall in all respects be pari passu security interests on parity with the security interests granted or to be granted in the Collateral to the holder of the New Notes pursuant to the Amended Security Agreement. Such Senior Holders confirm and agree that the priorities specified herein are applicable irrespective of the time, order or method of attachment or perfection of security interests or the time or order of filing of financing statements and each agrees not to seek to challenge, to avoid, to subordinate or to contest or directly or indirectly to support any other person in challenging, avoiding, subordinating or contesting in any judicial or other proceeding, including, without limitation, any proceeding involving the Company, the priority, validity, extent, perfection or enforceability of any lien held by the holders of the New Notes in all or any part of the Collateral.

 

SECTION 5 .        Representations and Warranties . Each of the parties hereto represents and warrants that it is duly incorporated or otherwise organized, validly existing and (to the extent applicable) in good standing under the laws of the jurisdiction of its formation, that it has all requisite power and authority to enter into this Consent and that this Consent has been duly authorized, executed and delivered by it and constitutes its legal, valid and binding obligation. Each of the undersigned Senior Holders further represent and warrant that: (i) it is the beneficial or record owner of the Senior Note originally issued to it, free and clear of any and all pledges, liens, security interests, mortgage, claims, charges, restrictions, options, title defects or encumbrances; (ii) such Senior Holder has neither assigned, pledged or transferred in any manner, any interest in either the Senior Note originally issued to it or the Security Agreement; and (iii) it is an “accredited investor” as that term is defined in Regulation D promulgated under the Securities Act of 1933.

 

2

 

 

SECTION 6.      Effect of Amendment . This Consent shall become effective on the date on which (the “ Effective Date ”) the following conditions have occurred: (a) the Company and the undersigned Senior Holders have executed and delivered counterparts of this Consent and the Amended Security Agreement, and (b) the closing of the transactions contemplated under the new exchange agreement between the Company and the Exchanging Holders shall have occurred. At the Effective Time, (i) the applicable portions of this Consent shall be a part of each Convertible Senior Note, as amended hereby, and (ii) each reference in any such document to “this Note”, “hereof”, “hereunder”, or words of like import, and each reference in any other document or agreement to any of the Convertible Senior Notes shall mean and be a reference to the Convertible Senior Notes, as amended hereby. Except as expressly amended hereby, each of the Convertible Senior Notes amended herein shall remain in full force and effect and are hereby ratified and confirmed by the parties hereto. This Consent shall be affixed to the original of each Convertible Senior Note and become a part thereof.

 

SECTION 7 .       Governing Law; Miscellaneous .

 

(a)      This Consent shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflicts of law. Headings used herein are for convenience of reference only and shall not affect the meaning of this Consent. This Consent may be executed in any number of counterparts, and by the parties hereto on separate counterparts, each of which shall be an original and all of which taken together shall constitute one and the same agreement. Executed counterparts may be delivered via facsimile or other means of electronic transmission.

 

(b)       This Consent contains the entire agreement and understanding of the parties with respect to its subject matter and supersedes all prior arrangements and understandings between the parties, either written or oral, with respect to its subject matter. This Consent may not be amended or any provision hereof waived in whole or in part, except by a written amendment signed by all of the parties hereto. The observance of any term of this Consent may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument signed by the party against whom enforcement of any such waiver is sought. The failure of any party at any time or times to require performance of any provision hereof shall in no manner affect the rights at a later time to enforce the same. No waivers of or exceptions to any term, condition, or provision of this Consent, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition, or provision. This Consent shall be binding upon and shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns.

 

(c)      Each Senior Holder expressly represents and warrants that (a) before executing this Consent, such Senior Holder has fully informed himself or itself of the terms, contents, conditions and effects of this Amendment; (b) such Senior Holder has had the opportunity to seek the advice of his or its own counsel and advisors before executing this Consent; (c) this Consent is the result of arm’s length negotiations conducted by and among the parties; and (d) such Senior Holder acknowledges that the law firm of Becker & Poliakoff, LLP has been retained by the Company to prepare this Amendment as legal counsel for the Company, that Becker & Poliakoff, LLP does not represent any Senior Holder in connection with the preparation or execution of this Amendment, that such firm has not given any legal, investment or tax advice to any Senior Holder regarding this Consent and that such Senior Holder has not relied upon any legal advice except as provided by its own attorneys. Becker & Poliakoff, LLP is expressly intended as a beneficiary of the representations and warranties of the Senior Holder contained in this paragraph.

 

 

 [Signature Page Follows]

 

3

 

 

WITNESS WHEREOF , the parties have caused this Consent to be executed by their respective duly authorized representatives, as of the date first set forth above

 

 

AEON GLOBAL HEALTH C ORP.

 

 

 

By:   /s/ Michael J. Poelking        

Name: Michael J. Poelking      

Title: Chief Financial Officer

 

 

ACCEPTED AND AGREED:

 

MKA 79, LLC

 

 

By:          /s/ J. David Luce

Name:   J. David Luce

Title:     Manager

Principal Amount of Senior Note: $641,294

 

VER 83, LLC

 

 

By:          /s/ Douglas B. Luce

Name:   Douglas B. Luce     

Title:     Manager

Principal Amount of Senior Note: $1,056,875

 

 

 

 

 

 

 

Signature Page to Consent

 

4

 

 

EXHIBIT A

 

FORM OF AMENDED SECURITY AGREEMENT

 

5

  Exhibit 10.4

 

AMENDMENT NO. 2 TO AMENDED AND RESTATED SECURITY AGREEMENT

 

THIS AMENDMENT NO. 2 to the AMENDED AND RESTATED SECURITY AGREEMENT AMENDMENT (this “ Agreement ”) is made and entered into as of July 19, 2018 by Aeon Global Health Corp. (formerly, Authentidate Holding Corp.), a Delaware corporation (the “ Company ”) and each of the holders of the secured notes listed on the signature pages hereto (such persons, the “ Secured Parties ”).

 

W I T N E S S E T H:

 

WHEREAS, the Company entered into that certain Amended and Restated Security Agreement dated as of March 20, 2017 (the “ Original S ecurity Agreement ”) with the Secured Parties with respect to an aggregate principal amount of $2,545,199 of Senior Secured Convertible Notes due March 20, 2018 (the “ Prior S enior Notes ”);

 

WHEREAS, the Secured Parties and the Company entered into certain agreements dated March 27, 2018, pursuant to which the maturity date of the Prior Senior Notes were extended for one year and the aggregate principal amount of indebtedness outstanding thereunder was increased to $3,049,651; and

 

WHEREAS, the Company and the Secured Parties entered into an amendment to the Original Security Agreement, dated March 27, 2018 (such amendment, together with the Original Security Agreement, may be referred to herein as the “ Security Agreement ”), pursuant to which the Company granted liens on its assets to secure the additional indebtedness incurred under the Prior Senior Notes;

 

WHEREAS, the Company wishes to restructure an aggregate principal amount of $1,351,482 of Senior Notes held by Hanif A. Roshan and Optimum Ventures, LLC (the “ Exchanging Holders ”), pursuant to which the Exchanging Holders would exchange their Senior Notes for new, secured non-convertible debt instruments pursuant to which such Exchanging Holders would make available a maximum of $2.0 million of debt capital to the Company (the “ New Credit Facility ”), which New Credit Facility would be on a parity basis with the Prior Senior Notes;

 

WHEREAS, the Company wishes to obtain the consent of the Secured Parties to the establishment of the New Credit Facility and pursuant thereto issue up to an aggregate principal amount of $2.0 million of new senior secured notes on parity with the Prior Senior Notes, pursuant to which an aggregate principal amount of $1,415,449 would be deemed outstanding as of the date of issuance (the “ New Notes ”); and

 

WHEREAS, the Company and Secured Parties desire to amend and modify the Security Agreement to permit the establishment of the New Credit Facility and issuance of the New Notes on the terms set forth herein, and the undersigned Secured Parties have agreed to such amendments, modifications and other provisions set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing, the covenants set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Secured Parties and the Company hereby agree as follows.

 

1.             Certain Definitions .

 

1.1     Capitalized terms not otherwise defined herein shall have the meaning ascribed to such terms in the Security Agreement.

 

1

 

 

1.2     Section 1.1 of the Security Agreement is hereby amended to include the following additional definitions of the following terms:

 

(p)      “ New Notes ” shall have the meaning ascribed to such term as is set forth in the Recitals to this Amendment No. 2 to Amended and Restated Security Agreement.

 

1.3     Section 1.1 of the Security Agreement is hereby amended to replace the definitions of the following terms set forth in the Security Agreement with the following definitions:

 

(a)     “ Majority in Interest ” shall mean the holders of fifty-one percent (51%) or more of the then outstanding aggregate principal amount of the Secured Notes, at the time of such determination.

 

(b)     “ Secured Notes ” means the Prior Senior Notes and the New Notes, as may be amended from time to time.

 

(c)     “ Secured Parties ” means the holders of the Secured Notes, at the time of such determination.           

 

2.             Amendment and Restatement of Section II of the Original Security Agreement.

 

(a)      Section 2.1 of the Original Security Agreement is hereby amended and restated to read as follows:

 

2.1      Grant and Description . In order to secure the full and complete payment and performance of the Obligations when due, including the New Notes, the Company hereby grants to the Secured Parties, subject to the Permitted Liens, a first priority security interest in all of the Company’s rights, titles, and interests in and to the Collateral (the “ Security Interest ”) and subject to the Permitted Liens, pledges, collaterally transfers, and assigns the Collateral to the Secured Parties, all upon and subject to the terms and conditions of this Security Agreement;  provided however , that each Secured Party shall subordinate from time to time upon the Company’s request its Security Interests granted in such Collateral to any Lien(s) granted by the Company or any of its Subsidiaries to third parties which constitutes Permitted Liens contemplated within clauses (h) through (k) of the definition of Permitted Liens. If the grant, pledge, or collateral transfer or assignment of any specific item of the Collateral is expressly prohibited by any contract or by law, then the Security Interest created hereby nonetheless remains effective to the extent allowed by such contract, the UCC or other applicable laws, but is otherwise limited by that prohibition. The Security Interest granted herein shall terminate in accordance with Section 7.1 hereof.

 

(b)      Section 2.2 of the Original Security Agreement is hereby amended and restated to read as follows:

 

2.2      Financing Statements; Further Assurances .

 

(a)    The Secured Parties shall be named as the sole secured parties on any and all financing statements and security agreements filed pursuant to this Security Agreement for the ratable benefit of all of the Secured Parties, and agree that the Majority in Interest of the Secured Parties are authorized to file any and all terminations of such financing statements at such time or times as it determines is appropriate pursuant to the Security Agreement.

 

2

 

 

(b)    As soon as practicable following the execution and delivery of this Security Agreement, the Company shall:

 

(i)    file with the State of Delaware and any other offices that the Majority in Interest of the Secured Parties may reasonably request in writing an amended financing statement that (x) indicates the Collateral in a manner consistent with the definition of the term “Collateral” as contained in this Security Agreement, (y) contains any other information required by Article 9 of the UCC of the state or such jurisdiction for the sufficiency or filing office acceptance of any financing statement or amendment, including whether the Company is an organization, the type of organization, and any organization identification number issued to the Company, and (z) reflects Roshan as an additional secured party in order to secure the obligations arising under the New Roshan Note;

 

(ii)   if necessary to perfect the Security Interest granted in the Collateral hereunder, file with the U.S. Patent and Trademark Office, such amended financing statements and/or patent security agreements in the form necessary to record the Liens granted hereunder to the Secured Parties on the Company’s patents and patent applications; and

  

(iii)   upon the reasonable request of the Majority in Interest of the Secured Parties, file such additional financing statements and other documents, including amendments to the financing statements, in order to maintain the Liens in the Collateral.

 

(c)     Until the Obligations are paid and performed in full, the Company covenants and agrees that it will, at its own expense and upon the request of the Majority in Interest, but in all cases subject to the rights of the grantees of the Permitted Liens: (i) after an Event of Default, file or cause to be filed such applications and take such other actions as the Majority in Interest may reasonably request to obtain the consent or approval of any governmental authority to the rights of the Secured Parties hereunder, including, without limitation, the right to sell all the Collateral upon an Event of Default without additional consent or approval from such governmental authority; (ii) from time to time, either before or after an Event of Default, promptly execute and deliver to the Secured Parties all such other assignments, certificates, supplemental documents, and financing statements, and do all other acts or things as the Majority in Interest may reasonably request in order to more fully create, evidence, perfect, continue, and preserve the priority of the Security Interest and to carry out the provisions of this Security Agreement; and (iii) either before or after an Event of Default, pay all filing fees in connection with any financing, continuation, or termination statement or other instrument with respect to the Security Interest.

 

3.             Interpretation of Certain Terms .

 

Each of the Secured Parties and the Company hereby acknowledge, consent and agree that for purposes of the Security Agreement, as amended by this Agreement, (i) the term Obligations includes all obligations under the New Notes on a pari passu basis with the Prior Senior Notes; and (ii) the holders of the New Notes shall be entitled to all rights as a Secured Party hereunder and may fully enforce their rights under the New Notes, as if such New Notes was within the definition of the term “Secured Notes” as set forth in the Security Agreement.

 

4.            Continuing Validity of Security Agreement. Except as amended under this Agreement, the Security Agreement shall remain in full force and effect. Upon the execution of this Agreement by the Company and the Secured Parties, (i) the applicable portions of this Agreement shall be a part of the Security Agreement, each as amended hereby, and (ii) each reference in the Security Agreement to “this Agreement”, “hereof”, “hereunder”, or words of like import, and each reference in any other document or agreement to the Security Agreement shall mean and be a reference to the Security Agreement, as amended hereby.

 

3

 

 

5.           Governing Law . This Agreement shall be governed by and construed under the laws of the State of Delaware, without reference to principles of conflicts of law.

 

6.           Headings . The headings used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

7.           Multiple Counterparts . This Agreement has been executed in a number of identical counterparts, each of which shall be deemed an original for all purposes and all of which constitute, collectively, one agreement; but, in making proof of this Agreement, it shall not be necessary to produce or account for more than one such counterpart. Executed counterparts may be delivered via facsimile or other means of electronic transmission.

 

8.           Entire Agreement; Amendments and Waivers . This Agreement contains the entire agreement and understanding of the parties with respect to its subject matter and supersedes all prior arrangements and understandings between the parties, either written or oral, with respect to its subject matter. This Agreement may not be amended or any provision hereof waived in whole or in part, except by a written amendment signed by all of the parties hereto. The observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument signed by the party against whom enforcement of any such waiver is sought. The failure of any party at any time or times to require performance of any provision hereof shall in no manner affect the rights at a later time to enforce the same. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition, or provision. This Agreement shall be binding upon and shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns.

 

9.           Separate Counsel . Each of the Secured Parties expressly represents and warrants that (a) before executing this Agreement, such Secured Party has fully informed himself or itself of the terms, contents, conditions and effects of this Agreement; (b) such Secured Party has had the opportunity to seek the advice of his or its own counsel and advisors before executing this Agreement; (c) this Agreement is the result of arm’s length negotiations conducted by and among the parties; and (d) such Secured Party acknowledges that the law firm of Becker & Poliakoff, LLP has been retained by the Company to prepare this Agreement as legal counsel for the Company, that Becker & Poliakoff, LLP does not represent any Secured Party in connection with the preparation or execution of this Agreement, that such firm has not given any legal, investment or tax advice to any of the Secured Parties regarding this Agreement and that such Secured Party has not relied upon any legal advice except as provided by its own attorneys. Becker & Poliakoff, LLP is expressly intended as a beneficiary of the representations and warranties of the Secured Parties contained in this paragraph.

 

 

 

Remainder of page intentionally left blank. Signature page s follow.

 

4

 

 

AMENDMENT NO. 2 to AMENDED AND RESTATED SECURITY AGREEMENT

 

IN WITNESS WHEREOF, the Company and the Secured Parties have duly executed this Agreement as of the date first written above.

 

 

AEON GLOBAL HEALTH CORP.

   
   
 

By:

 /s/ Michael J. Poelking                                                    

   

Name:

Michael J. Poelking

   

Title:

Chief Financial Officer

       
 

Address for Notice:

   
 

2225 Centennial Drive

Gainesville, GA 30504

Attn: Chief Financial Officer

   
SECURED PART IES:  
   
VER 83 LLC MKA 79 LLC
   
   
By: /s/ Douglas B. Luce   By:   /s/ J. David Luce
Name: Name:
Title: Title:
   
   
OPTIMUM VENTURES, LLC HANIF A. ROSHAN
   
   
By:   /s/ Shawn Desai                                                        By:   /s/ Hanif A. Roshan
Name:  
Title: